{"content":"<li class=\"n-box-item date-title\" data-end=\"1362027599\" data-start=\"1361941200\" data-txt=\"Friday, December 20, 2019\">Wednesday, February 27, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"857291\" data-ts=\"1362010841\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRT\" target=\"_blank\">CPRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/857291\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Copart (NASDAQ:CPRT): FQ2 EPS of $0.31 misses by $0.05. Revenue of $266.2M beats by $22M. Shares...</a></h4><b>Copart (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CPRT\" title=\"Copart, Inc.\">CPRT</a>):</b> FQ2 EPS of $0.31 <font color=\"red\">misses by $0.05</font>. Revenue of $266.2M <font color=\"green\">beats by $22M</font>. Shares <font color=\"red\">-1.7%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"857291\" data-linked=\"Copart (NASDAQ:CPRT): FQ2 EPS of $0.31 misses by $0.05. Revenue of $266.2M beats by $22M. Shares...\" data-tweet=\"$CPRT - Copart (NASDAQ:CPRT): FQ2 EPS of $0.31 misses by $0.05. Revenue of $266.2M beats by $22M. Shares -1.7% AH. (PR) https://seekingalpha.com/news/857291?source=tweet\" data-url=\"https://seekingalpha.com/news/857291\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856931\" data-ts=\"1362006717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGNC\" target=\"_blank\">AGNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856931\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Capital Agency (NASDAQ:AGNC) announces a 50M share secondary offering. The company...</a></h4><p>American Capital Agency (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AGNC\" title=\"AGNC Investment Corp.\">AGNC</a>) announces a 50M share secondary offering. The company expects to use net proceeds from the offering to acquire additional agency securities as market conditions warrant and for general corporate purposes. BAML, Citigroup, Credit Suisse, Goldman, Sachs, JPMorgan and Morgan Stanley are all joint book-running managers. Shares <font color=\"red\">-3%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"856931\" data-linked=\"American Capital Agency (NASDAQ:AGNC) announces a 50M share secondary offering. The company...\" data-tweet=\"$AGNC - American Capital Agency (NASDAQ:AGNC) announces a 50M share secondary offering. The company expects to use net proceeds from the offering to acquire additional agency securities as market conditions warrant and for general corporate purposes. BA... https://seekingalpha.com/news/856931?source=tweet\" data-url=\"https://seekingalpha.com/news/856931\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856781\" data-ts=\"1362005512\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TDC\" target=\"_blank\">TDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856781\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">In spite of a market rally, Teradata (TDC -3.4%) slumped for the second day in a row. The...</a></h4><p>In spite of a market rally, Teradata (<a href=\"https://seekingalpha.com/symbol/TDC\" title=\"Teradata Corporation\">TDC</a> <font color=\"red\">-3.4%</font>) slumped for the second day in a row. The apparent culprit: a somewhat downbeat presentation from CFO Stephen Scheppmann on Tuesday at a Morgan Stanley conference (<a href=\"https://seekingalpha.com/article/1226981-teradata-s-management-presents-at-morgan-stanley-technology-media-telecom-conference-transcript?source=yahoo\" target=\"_blank\">transcript</a>). Though Teradata's pipeline is solid, the company isn't seeing U.S. customers commit to $10M+ deals, Scheppmann stated. He insisted Teradata is mostly still competing with traditional data warehousing rivals IBM and Oracle, rather than analytics upstarts such as SAP (<a href=\"https://seekingalpha.com/currents/search?query=sap%20hana\" target=\"_blank\">Hana</a>) and EMC (<a href=\"https://seekingalpha.com/currents/search?query=greenplum\" target=\"_blank\">Greenplum</a>).</p><div class=\"tiny-share-widget\" data-id=\"856781\" data-linked=\"In spite of a market rally, Teradata (TDC -3.4%) slumped for the second day in a row. The...\" data-tweet=\"$TDC - In spite of a market rally, Teradata (TDC -3.4%) slumped for the second day in a row. The apparent culprit: a somewhat downbeat presentation from CFO Stephen Scheppmann on Tuesday at a Morgan Stanley conference (transcript). Though Teradata&#39;s pip... https://seekingalpha.com/news/856781?source=tweet\" data-url=\"https://seekingalpha.com/news/856781\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856771\" data-ts=\"1362005432\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANIK\" target=\"_blank\">ANIK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856771\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anika Therapeutics (NASDAQ:ANIK): Q4 EPS of $0.31 beats by $0.07. Revenue of $22.6M (+23% Y/Y)...</a></h4><b>Anika Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ANIK\" title=\"Anika Therapeutics Inc.\">ANIK</a>):</b> Q4 EPS of $0.31 <font color=\"green\">beats by $0.07</font>. Revenue of $22.6M (+23% Y/Y) <font color=\"green\">beats by $1M</font>. Shares <font color=\"green\">+3.3%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"856771\" data-linked=\"Anika Therapeutics (NASDAQ:ANIK): Q4 EPS of $0.31 beats by $0.07. Revenue of $22.6M (+23% Y/Y)...\" data-tweet=\"$ANIK - Anika Therapeutics (NASDAQ:ANIK): Q4 EPS of $0.31 beats by $0.07. Revenue of $22.6M (+23% Y/Y) beats by $1M. Shares +3.3% AH. (PR) https://seekingalpha.com/news/856771?source=tweet\" data-url=\"https://seekingalpha.com/news/856771\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856741\" data-ts=\"1362005189\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BWXT\" target=\"_blank\">BWXT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856741\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers, as of 5:15 p.m.: BWC +9%. ARAY +4%. IDIX +4%. CLDX +3%. UAN +3%....</a></h4><b>After-hours top gainers, as of 5:15 p.m.:</b> BWC <font color=\"green\">+9%</font>. <a href='https://seekingalpha.com/symbol/ARAY' title='Accuray Incorporated'>ARAY</a> <font color=\"green\">+4%</font>. <a href='https://seekingalpha.com/symbol/IDIX' title='Idenix Pharmaceuticals, Inc.'>IDIX</a> <font color=\"green\">+4%</font>. <a href='https://seekingalpha.com/symbol/CLDX' title='Celldex Therapeutics, Inc'>CLDX</a> <font color=\"green\">+3%</font>. <a href='https://seekingalpha.com/symbol/UAN' title='CVR Partners, LP'>UAN</a> <font color=\"green\">+3%</font>. <br /><b>After-hours top losers:</b> <a href='https://seekingalpha.com/symbol/GRPN' title='Groupon, Inc.'>GRPN</a> <font color=\"red\">-25%</font>. BSFT <font color=\"red\">-23%</font>. <a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a> <font color=\"red\">-14%</font>. <a href='https://seekingalpha.com/symbol/VCRA' title='Vocera Communications'>VCRA</a> <font color=\"red\">-12%</font>. <a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a> <font color=\"red\">-9%</font>.<div class=\"tiny-share-widget\" data-id=\"856741\" data-linked=\"After-hours top gainers, as of 5:15 p.m.: BWC +9%. ARAY +4%. IDIX +4%. CLDX +3%. UAN +3%....\" data-tweet=\"$BWXT $BWXT $ARAY - After-hours top gainers, as of 5:15 p.m.: BWC +9%. ARAY +4%. IDIX +4%. CLDX +3%. UAN +3%. After-hours top losers: GRPN -25%. BSFT -23%. OTC:ANW -14%. VCRA -12%. JCP -9%. https://seekingalpha.com/news/856741?source=tweet\" data-url=\"https://seekingalpha.com/news/856741\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856581\" data-ts=\"1362003670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VCRA\" target=\"_blank\">VCRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856581\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vocera (NYSE:VCRA): Q4 EPS of $0.10 beats by $0.03. Revenue of $27M (+24% Y/Y) misses by $0.35M....</a></h4><b>Vocera (NYSE:<a href=\"https://seekingalpha.com/symbol/VCRA\" title=\"Vocera Communications\">VCRA</a>):</b> Q4 EPS of $0.10 <font color=\"green\">beats by $0.03</font>. Revenue of $27M (+24% Y/Y) <font color=\"red\">misses by $0.35M</font>. Shares  <font color=\"red\">-11.6%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"856581\" data-linked=\"Vocera (NYSE:VCRA): Q4 EPS of $0.10 beats by $0.03. Revenue of $27M (+24% Y/Y) misses by $0.35M....\" data-tweet=\"$VCRA - Vocera (NYSE:VCRA): Q4 EPS of $0.10 beats by $0.03. Revenue of $27M (+24% Y/Y) misses by $0.35M. Shares -11.6% AH. (PR) https://seekingalpha.com/news/856581?source=tweet\" data-url=\"https://seekingalpha.com/news/856581\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856561\" data-ts=\"1362003520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYL\" target=\"_blank\">MYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856561\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mylan (NASDAQ:MYL) acquires Agila Specialties, a developer, manufacturer and marketer of...</a></h4><p>Mylan (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MYL\" title=\"Mylan Inc\">MYL</a>) acquires Agila Specialties, a developer, manufacturer and marketer of high-quality generic injectable products, from Strides Arcolab for $1.6B in cash. The acquisition significantly expands <a href=\"https://seekingalpha.com/symbol/MYL\" title=\"Mylan Inc\">MYL</a>'s global injectables platform and will provide entry into new high-growth geographic markets. The acquisition is expected to close in Q4 of 2013 should be immediately accretive to earnings. Shares <font color=\"green\">+1.8%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"856561\" data-linked=\"Mylan (NASDAQ:MYL) acquires Agila Specialties, a developer, manufacturer and marketer of...\" data-tweet=\"$MYL - Mylan (NASDAQ:MYL) acquires Agila Specialties, a developer, manufacturer and marketer of high-quality generic injectable products, from Strides Arcolab for $1.6B in cash. The acquisition significantly expands MYL&#39;s global injectables platform and... https://seekingalpha.com/news/856561?source=tweet\" data-url=\"https://seekingalpha.com/news/856561\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856551\" data-ts=\"1362003458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UAN\" target=\"_blank\">UAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856551\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on CVR Partners (NYSE:UAN) Q4 earnings: Removing the biennial turnaround at the Coffeyville...</a></h4><p>More on CVR Partners (NYSE:<a href=\"https://seekingalpha.com/symbol/UAN\" title=\"CVR Partners, LP\">UAN</a>) Q4 <a href=\"https://seekingalpha.com/currents/post/856421\" target=\"_blank\">earnings</a>: Removing the biennial turnaround at the Coffeyville plant brings adjusted EBITDA/share to $0.37, 76% higher than the headline number. Average gate price for ammonia of $676/ton, up from $606 a year ago. UAN price of $274/ton, down from $334 a year ago. 2013 distribution guidance of $2.15-$2.45/share ($1.81 in 2012), includes a favorable settlement in property tax dispute with Montg. Co., Kansas. Shares <font color=\"green\">+2.8%</font> AH. (PR)</p><div class=\"tiny-share-widget\" data-id=\"856551\" data-linked=\"More on CVR Partners (NYSE:UAN) Q4 earnings: Removing the biennial turnaround at the Coffeyville...\" data-tweet=\"$UAN - More on CVR Partners (NYSE:UAN) Q4 earnings: Removing the biennial turnaround at the Coffeyville plant brings adjusted EBITDA/share to $0.37, 76% higher than the headline number. Average gate price for ammonia of $676/ton, up from $606 a year ago... https://seekingalpha.com/news/856551?source=tweet\" data-url=\"https://seekingalpha.com/news/856551\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856541\" data-ts=\"1362003376\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGR\" target=\"_blank\">RGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856541\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sturm Ruger (NYSE:RGR): Q4 EPS of $1.00 beats by $0.18. Revenue of $141.8M (+52% Y/Y) beats by...</a></h4><b>Sturm Ruger (NYSE:<a href=\"https://seekingalpha.com/symbol/RGR\" title=\"Sturm, Ruger &amp; Company Inc.\">RGR</a>):</b> Q4 EPS of $1.00 <font color=\"green\">beats by $0.18</font>. Revenue of $141.8M (+52% Y/Y) <font color=\"green\">beats by $17.8M</font>. Shares  <font color=\"green\">+1.8%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"856541\" data-linked=\"Sturm Ruger (NYSE:RGR): Q4 EPS of $1.00 beats by $0.18. Revenue of $141.8M (+52% Y/Y) beats by...\" data-tweet=\"$RGR - Sturm Ruger (NYSE:RGR): Q4 EPS of $1.00 beats by $0.18. Revenue of $141.8M (+52% Y/Y) beats by $17.8M. Shares +1.8% AH. (PR) https://seekingalpha.com/news/856541?source=tweet\" data-url=\"https://seekingalpha.com/news/856541\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856451\" data-ts=\"1362002652\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LB\" target=\"_blank\">LB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856451\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Limited (LTD): Q4 EPS of $1.76 beats by $0.02. Revenue of $3.85B beats by $0.09B. Shares -1.5%...</a></h4><b>Limited (LTD):</b> Q4 EPS of $1.76 <font color=\"green\">beats by $0.02</font>. Revenue of $3.85B <font color=\"green\">beats by $0.09B</font>. Shares  <font color=\"red\">-1.5%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"856451\" data-linked=\"Limited (LTD): Q4 EPS of $1.76 beats by $0.02. Revenue of $3.85B beats by $0.09B. Shares -1.5%...\" data-tweet=\"$LB - Limited (LTD): Q4 EPS of $1.76 beats by $0.02. Revenue of $3.85B beats by $0.09B. Shares -1.5% AH. (PR) https://seekingalpha.com/news/856451?source=tweet\" data-url=\"https://seekingalpha.com/news/856451\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856441\" data-ts=\"1362002575\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYL\" target=\"_blank\">MYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856441\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mylan Labs (NASDAQ:MYL): Q4 EPS of $0.65 beats by $0.02. Revenue of $1.72B (+13% Y/Y) misses by...</a></h4><b>Mylan Labs (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MYL\" title=\"Mylan Inc\">MYL</a>):</b> Q4 EPS of $0.65 <font color=\"green\">beats by $0.02</font>. Revenue of $1.72B (+13% Y/Y) <font color=\"red\">misses by $0.01B</font>. Shares  <font color=\"red\">-2%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"856441\" data-linked=\"Mylan Labs (NASDAQ:MYL): Q4 EPS of $0.65 beats by $0.02. Revenue of $1.72B (+13% Y/Y) misses by...\" data-tweet=\"$MYL - Mylan Labs (NASDAQ:MYL): Q4 EPS of $0.65 beats by $0.02. Revenue of $1.72B (+13% Y/Y) misses by $0.01B. Shares -2% AH. (PR) https://seekingalpha.com/news/856441?source=tweet\" data-url=\"https://seekingalpha.com/news/856441\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856431\" data-ts=\"1362002567\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856431\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Following a halt, BroadSoft (BSFT) -22.4% AH in response to its Q4 report. Though results beat...</a></h4><p>Following a halt, BroadSoft (BSFT) <strong><font color=\"red\">-22.4%</font></strong> AH in response to its <a href=\"https://seekingalpha.com/currents/post/856111\" target=\"_blank\">Q4 report</a>. Though results beat estimates, the company expects Q1 revenue of $37M-$40M and EPS of $0.02-$0.12, below a consensus of $43.6M and $0.34. 2013 guidance is for revenue of $181M-$189M and EPS of $1.10-$1.35, below a consensus of $196.9M and $1.72. BroadSoft blames lower revenue for consumer apps deployed by service providers prior to <a href=\"http://www.digitaltrends.com/mobile/volte-testing-can/\" target=\"_blank\">VoLTE</a> investments, and soft services revenue. Shares <font color=\"red\">fell 7.3%</font> in regular trading - did someone know something in advance? (PR)</p><div class=\"tiny-share-widget\" data-id=\"856431\" data-linked=\"Following a halt, BroadSoft (BSFT) -22.4% AH in response to its Q4 report. Though results beat...\" data-tweet=\"$CSCO - Following a halt, BroadSoft (BSFT) -22.4% AH in response to its Q4 report. Though results beat estimates, the company expects Q1 revenue of $37M-$40M and EPS of $0.02-$0.12, below a consensus of $43.6M and $0.34. 2013 guidance is for revenue of ... https://seekingalpha.com/news/856431?source=tweet\" data-url=\"https://seekingalpha.com/news/856431\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856401\" data-ts=\"1362002282\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856401\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&quot;Simply stunning results&quot; from J.C. Penney (NYSE:JCP), says Tiburon Research&#39;s Rob Wilson,...</a></h4><p>\"Simply stunning results\" from J.C. Penney (NYSE:<a href=\"https://seekingalpha.com/symbol/JCP\" title=\"J.C. Penney Company Inc.\">JCP</a>), says Tiburon Research's Rob Wilson, <a href=\"https://twitter.com/RetailRobWilson/status/306881799475302400\" target=\"_blank\">quickly reminding</a> it's 2-month old data. \"Frankly, what matters now is February. Did February materially improve vs. (the) Q4 disaster.\" Video <a href=\"http://ir.jcpenney.com/phoenix.zhtml?c=70528&amp;p=irol-irHome\" target=\"_blank\">conference call</a> begins momentarily. Shares <font color=\"red\">-9.3%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"856401\" data-linked=\"&quot;Simply stunning results&quot; from J.C. Penney (NYSE:JCP), says Tiburon Research&#39;s Rob Wilson,...\" data-tweet=\"$JCP - &quot;Simply stunning results&quot; from J.C. Penney (NYSE:JCP), says Tiburon Research&#39;s Rob Wilson, quickly reminding it&#39;s 2-month old data. &quot;Frankly, what matters now is February. Did February materially improve vs. (the) Q4 disaster.&quot; Video conference c... https://seekingalpha.com/news/856401?source=tweet\" data-url=\"https://seekingalpha.com/news/856401\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856341\" data-ts=\"1362001874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBI\" target=\"_blank\">MBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856341\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on MBIA (NYSE:MBI) Q4 earnings: Adjusted book value of $30.68/share, up marginally from Q3,...</a></h4><p>More on MBIA (NYSE:<a href=\"https://seekingalpha.com/symbol/MBI\" title=\"MBIA Inc.\">MBI</a>) Q4 <a href=\"https://seekingalpha.com/currents/post/856011\" target=\"_blank\">earnings</a>: Adjusted book value of $30.68/share, up marginally from Q3, down from $34.50 a year ago. \"MBIA's (liquidity and capital) forecast assumes a comprehensive settlement with BofA ... and the collection of a substantial portion of MBIA's put-back claims against BofA/Countrywide ... (we) believe it is more likely than not that a timely settlement will be reached.\" Shares <font color=\"green\">+3.2%</font> AH. (PR)</p><div class=\"tiny-share-widget\" data-id=\"856341\" data-linked=\"More on MBIA (NYSE:MBI) Q4 earnings: Adjusted book value of $30.68/share, up marginally from Q3,...\" data-tweet=\"$MBI - More on MBIA (NYSE:MBI) Q4 earnings: Adjusted book value of $30.68/share, up marginally from Q3, down from $34.50 a year ago. &quot;MBIA&#39;s (liquidity and capital) forecast assumes a comprehensive settlement with BofA . and the collection of a substant... https://seekingalpha.com/news/856341?source=tweet\" data-url=\"https://seekingalpha.com/news/856341\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856281\" data-ts=\"1362001462\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856281\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on J.C. Penney&#39;s (NYSE:JCP) Q4: No sign of relief for investors just yet as the firm...</a></h4><p>More on J.C. Penney's (NYSE:<a href=\"https://seekingalpha.com/symbol/JCP\" title=\"J.C. Penney Company Inc.\">JCP</a>) Q4: No sign of relief for investors just yet as the firm reports comparable store sales fell 31.7%, below the consensus call of -26.9%. Customer are fleeing, but no give up from CEO Ron Johnson: \"...we are energized by our shop roll out plans.\" Gross margin was crushed, falling to 23.8% of sales vs. 30.2% last year. Internet sales slumped again, losing 34.4% Y/Y just marginally better than last quarter's 37% nosedive. Cash position $930M at end of Q4. No guidance is issued, but the retailer says it will open 20 shops geared toward home products in 505 stores with brand partners. JCP <font color=\"red\">-4.4%</font> AH.  (PR)</p><div class=\"tiny-share-widget\" data-id=\"856281\" data-linked=\"More on J.C. Penney&#39;s (NYSE:JCP) Q4: No sign of relief for investors just yet as the firm...\" data-tweet=\"$JCP - More on J.C. Penney&#39;s (NYSE:JCP) Q4: No sign of relief for investors just yet as the firm reports comparable store sales fell 31.7%, below the consensus call of -26.9%. Customer are fleeing, but no give up from CEO Ron Johnson: &quot;.we are energized... https://seekingalpha.com/news/856281?source=tweet\" data-url=\"https://seekingalpha.com/news/856281\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856231\" data-ts=\"1362000951\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANW\" target=\"_blank\">ANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856231\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aegean Marine Petrol (OTC:ANW): Q4 EPS of $0.11 misses by $0.07. Revenue of $1.73B misses by...</a></h4><b>Aegean Marine Petrol (<a href=\"https://seekingalpha.com/symbol/ANW\" title=\"Aegean Marine Petroleum Network Inc.\">OTC:ANW</a>):</b> Q4 EPS of $0.11 <font color=\"red\">misses by $0.07</font>. Revenue of $1.73B <font color=\"red\">misses by $0.02B</font>. Shares  <font color=\"red\">-11.2%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"856231\" data-linked=\"Aegean Marine Petrol (OTC:ANW): Q4 EPS of $0.11 misses by $0.07. Revenue of $1.73B misses by...\" data-tweet=\"$ANW - Aegean Marine Petrol (OTC:ANW): Q4 EPS of $0.11 misses by $0.07. Revenue of $1.73B misses by $0.02B. Shares -11.2% AH. (PR) https://seekingalpha.com/news/856231?source=tweet\" data-url=\"https://seekingalpha.com/news/856231\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856221\" data-ts=\"1362000897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856221\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.C. Penney (NYSE:JCP): Q4 EPS of -$0.24 misses by $0.06. Revenue of $3.884B misses by $200M....</a></h4><b>J.C. Penney (NYSE:<a href=\"https://seekingalpha.com/symbol/JCP\" title=\"J.C. Penney Company Inc.\">JCP</a>):</b> Q4 EPS of -$0.24 <font color=\"red\">misses by $0.06</font>. Revenue of $3.884B <font color=\"red\">misses by $200M</font>. The firm's video earnings call is scheduled for 5:00 PM EST. JCP <font color=\"red\">-8.1%</font> AH. (<a target=\"_blank\" href=\"http://ir.jcpenney.com/phoenix.zhtml?c=70528&amp;p=irol-irHome\">webcast</a>; <a href=\"https://seekingalpha.com/article/1231641-j-c-penney-s-ceo-discusses-q4-2012-results-earnings-call-transcript\" target=\"_blank\">call transcript</a>) (PR)<div class=\"tiny-share-widget\" data-id=\"856221\" data-linked=\"J.C. Penney (NYSE:JCP): Q4 EPS of -$0.24 misses by $0.06. Revenue of $3.884B misses by $200M....\" data-tweet=\"$JCP - J.C. Penney (NYSE:JCP): Q4 EPS of -$0.24 misses by $0.06. Revenue of $3.884B misses by $200M. The firm&#39;s video earnings call is scheduled for 5:00 PM EST. JCP -8.1% AH. (webcast; call transcript) (PR) https://seekingalpha.com/news/856221?source=tweet\" data-url=\"https://seekingalpha.com/news/856221\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856211\" data-ts=\"1362000863\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CECO\" target=\"_blank\">CECO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856211\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Career Education (NASDAQ:CECO): Q4 EPS of -$0.35 misses by $0.01. Revenue of $354.7M. Shares...</a></h4><b>Career Education (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CECO\" title=\"Career Education Corporation\">CECO</a>):</b> Q4 EPS of -$0.35 <font color=\"red\">misses by $0.01</font>. Revenue of $354.7M. Shares  <font color=\"green\">+1.1%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"856211\" data-linked=\"Career Education (NASDAQ:CECO): Q4 EPS of -$0.35 misses by $0.01. Revenue of $354.7M. Shares...\" data-tweet=\"$CECO - Career Education (NASDAQ:CECO): Q4 EPS of -$0.35 misses by $0.01. Revenue of $354.7M. Shares +1.1% AH. (PR) https://seekingalpha.com/news/856211?source=tweet\" data-url=\"https://seekingalpha.com/news/856211\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856191\" data-ts=\"1362000568\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BWXT\" target=\"_blank\">BWXT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856191\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Babcock &amp;amp; Wilcox (BWC): Q4 beats on all counts as total sales rise 8.1% Y/Y. Power...</a></h4>More on Babcock &amp; Wilcox (BWC): <a href=\"https://seekingalpha.com/market_currents/post/856101\" target=\"_blank\">Q4 beats</a> on all counts as total sales rise 8.1% Y/Y. Power Generation segment revenues +9% on increased new-build environmental equipment revenues. Nuclear Operations segment revenues +12.2%, Nuclear Energy segment revenues -3.7%, Technical Services revenues -10.9%. For FY/13 the company sees an EPS of $2.25 - 2.45 versus $2.10 analyst estimate. Shares <font color=\"green\">+9%</font> AH.<div class=\"tiny-share-widget\" data-id=\"856191\" data-linked=\"More on Babcock &amp;amp; Wilcox (BWC): Q4 beats on all counts as total sales rise 8.1% Y/Y. Power...\" data-tweet=\"$BWXT - More on Babcock &amp; Wilcox (BWC): Q4 beats on all counts as total sales rise 8.1% Y/Y. Power Generation segment revenues +9% on increased new-build environmental equipment revenues. Nuclear Operations segment revenues +12.2%, Nuclear Energy segmen... https://seekingalpha.com/news/856191?source=tweet\" data-url=\"https://seekingalpha.com/news/856191\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856121\" data-ts=\"1362000118\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DXPE\" target=\"_blank\">DXPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856121\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DXP Enterprises (NASDAQ:DXPE): Q4 EPS of $0.92 beats by $0.09. Revenue of $293M (+34.2% Y/Y)...</a></h4><b>DXP Enterprises (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DXPE\" title=\"DXP Enterprises, Inc.\">DXPE</a>):</b> Q4 EPS of $0.92 <font color=\"green\">beats by $0.09</font>. Revenue of $293M (+34.2% Y/Y) <font color=\"green\">beats by $4.84M</font>. Shares  <font color=\"green\">+1.4%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"856121\" data-linked=\"DXP Enterprises (NASDAQ:DXPE): Q4 EPS of $0.92 beats by $0.09. Revenue of $293M (+34.2% Y/Y)...\" data-tweet=\"$DXPE - DXP Enterprises (NASDAQ:DXPE): Q4 EPS of $0.92 beats by $0.09. Revenue of $293M (+34.2% Y/Y) beats by $4.84M. Shares +1.4% AH. (PR) https://seekingalpha.com/news/856121?source=tweet\" data-url=\"https://seekingalpha.com/news/856121\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856101\" data-ts=\"1361999972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BWXT\" target=\"_blank\">BWXT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856101\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Babcock &amp;amp; Wilcox (BWC): Q4 EPS of $0.56 beats by $0.14. Revenue of $865.3M (+8.1% Y/Y) beats...</a></h4><b>Babcock &amp; Wilcox (BWC):</b> Q4 EPS of $0.56 <font color=\"green\">beats by $0.14</font>. Revenue of $865.3M (+8.1% Y/Y) <font color=\"green\">beats by $23.56M</font>. Shares  <font color=\"green\">+8.8%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"856101\" data-linked=\"Babcock &amp;amp; Wilcox (BWC): Q4 EPS of $0.56 beats by $0.14. Revenue of $865.3M (+8.1% Y/Y) beats...\" data-tweet=\"$BWXT - Babcock &amp; Wilcox (BWC): Q4 EPS of $0.56 beats by $0.14. Revenue of $865.3M (+8.1% Y/Y) beats by $23.56M. Shares +8.8% AH. (PR) https://seekingalpha.com/news/856101?source=tweet\" data-url=\"https://seekingalpha.com/news/856101\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856091\" data-ts=\"1361999906\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HNSN\" target=\"_blank\">HNSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856091\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Hansen Medical (NASDAQ:HNSN): Q4 beats on a per share basis but comes up short on the...</a></h4><p>More on Hansen Medical (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HNSN\" title=\"Hansen Medical, Inc.\">HNSN</a>): <a href=\"https://seekingalpha.com/market_currents/post/856021\" target=\"_blank\">Q4 beats</a> on a per share basis but comes up short on the revenue side. Catheter sales were up 22% compared to 2011 and up 18% sequentially. Procedures up 15% sequentially and 19% Y/Y, marking the sixth consecutive quarter of procedure growth. For FY13 the company anticipates growth in total robotic system shipments compared to 2012, as well as growth in procedures and catheter sales. Shares <font color=\"red\">-3%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"856091\" data-linked=\"More on Hansen Medical (NASDAQ:HNSN): Q4 beats on a per share basis but comes up short on the...\" data-tweet=\"$HNSN - More on Hansen Medical (NASDAQ:HNSN): Q4 beats on a per share basis but comes up short on the revenue side. Catheter sales were up 22% compared to 2011 and up 18% sequentially. Procedures up 15% sequentially and 19% Y/Y, marking the sixth consec... https://seekingalpha.com/news/856091?source=tweet\" data-url=\"https://seekingalpha.com/news/856091\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856041\" data-ts=\"1361999446\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNST\" target=\"_blank\">MNST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856041\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monster Beverage (NASDAQ:MNST): Q4 EPS of $0.39 misses by $0.02. Revenue of $471.5M (+15% Y/Y)...</a></h4><b>Monster Beverage (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MNST\" title=\"Monster Beverage Corp.\">MNST</a>):</b> Q4 EPS of $0.39 <font color=\"red\">misses by $0.02</font>. Revenue of $471.5M (+15% Y/Y) <font color=\"red\">misses by $12.11M</font>. Shares  <font color=\"red\">-5.2%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"856041\" data-linked=\"Monster Beverage (NASDAQ:MNST): Q4 EPS of $0.39 misses by $0.02. Revenue of $471.5M (+15% Y/Y)...\" data-tweet=\"$MNST - Monster Beverage (NASDAQ:MNST): Q4 EPS of $0.39 misses by $0.02. Revenue of $471.5M (+15% Y/Y) misses by $12.11M. Shares -5.2% AH. (PR) https://seekingalpha.com/news/856041?source=tweet\" data-url=\"https://seekingalpha.com/news/856041\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856031\" data-ts=\"1361999420\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRPN\" target=\"_blank\">GRPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856031\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Groupon (NASDAQ:GRPN): Q4 GAAP EPS of -$0.12 misses by $0.15. Revenue of $638.3M (+30% Y/Y)...</a></h4><b>Groupon (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GRPN\" title=\"Groupon, Inc.\">GRPN</a>):</b> Q4 GAAP EPS of -$0.12 <font color=\"red\">misses by $0.15</font>. Revenue of $638.3M (+30% Y/Y) in-line. Gross billings +24% Y/Y to $1.52B. Expects Q1 revenue of $560M-$610M, below $650.3M consensus. Expects Q1 operating income of -$10M to $10M. Shares <strong><font color=\"red\">-25.8%</font></strong> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"856031\" data-linked=\"Groupon (NASDAQ:GRPN): Q4 GAAP EPS of -$0.12 misses by $0.15. Revenue of $638.3M (+30% Y/Y)...\" data-tweet=\"$GRPN - Groupon (NASDAQ:GRPN): Q4 GAAP EPS of -$0.12 misses by $0.15. Revenue of $638.3M (+30% Y/Y) in-line. Gross billings +24% Y/Y to $1.52B. Expects Q1 revenue of $560M-$610M, below $650.3M consensus. Expects Q1 operating income of -$10M to $10M. Sha... https://seekingalpha.com/news/856031?source=tweet\" data-url=\"https://seekingalpha.com/news/856031\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"856021\" data-ts=\"1361999345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HNSN\" target=\"_blank\">HNSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/856021\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hansen Medical (NASDAQ:HNSN): Q4 EPS of $0.15 beats by $0.29. Revenue of $4.3M (-30% Y/Y) misses...</a></h4><b>Hansen Medical (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HNSN\" title=\"Hansen Medical, Inc.\">HNSN</a>):</b> Q4 EPS of $0.15 <font color=\"green\">beats by $0.29</font>. Revenue of $4.3M (-30% Y/Y) <font color=\"red\">misses by $1.62M</font>. Shares  <font color=\"green\">+3.1%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"856021\" data-linked=\"Hansen Medical (NASDAQ:HNSN): Q4 EPS of $0.15 beats by $0.29. Revenue of $4.3M (-30% Y/Y) misses...\" data-tweet=\"$HNSN - Hansen Medical (NASDAQ:HNSN): Q4 EPS of $0.15 beats by $0.29. Revenue of $4.3M (-30% Y/Y) misses by $1.62M. Shares +3.1% AH. (PR) https://seekingalpha.com/news/856021?source=tweet\" data-url=\"https://seekingalpha.com/news/856021\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855991\" data-ts=\"1361998998\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855991\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen Idec (BIIB +3%) finishes the day in the green after Canaccord upped the shares to Buy...</a></h4><p>Biogen Idec (<a href=\"https://seekingalpha.com/symbol/BIIB\" title=\"Biogen Inc.\">BIIB</a> <font color=\"green\">+3%</font>) finishes the day in the green after Canaccord <a href=\"http://www.streetinsider.com/Upgrades/Canaccord+Genuity+Upgrades+Biogen+%28BIIB%29+to+Buy/8136703.html\" target=\"_blank\">upped the shares</a> to Buy earlier and raised its price target from $163 to $187. The firm says that guidance implies stronger confidence in the TEC launch, and after chatting with end-users, it has more confidence in the initial phase of launch due to growing levels of patient warehousing.</p><div class=\"tiny-share-widget\" data-id=\"855991\" data-linked=\"Biogen Idec (BIIB +3%) finishes the day in the green after Canaccord upped the shares to Buy...\" data-tweet=\"$BIIB - Biogen Idec (BIIB +3%) finishes the day in the green after Canaccord upped the shares to Buy earlier and raised its price target from $163 to $187. The firm says that guidance implies stronger confidence in the TEC launch, and after chatting wit... https://seekingalpha.com/news/855991?source=tweet\" data-url=\"https://seekingalpha.com/news/855991\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855961\" data-ts=\"1361998665\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBB\" target=\"_blank\">CBB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855961\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Poor 2013 guidance has led Cincinnati Bell (CBB -21.3%) to crumble to new 52-week lows following...</a></h4><p>Poor 2013 guidance has led Cincinnati Bell (<a href=\"https://seekingalpha.com/symbol/CBB\" title=\"Cincinnati Bell Inc.\">CBB</a> <font color=\"red\">-21.3%</font>) to crumble to new 52-week lows following its <a href=\"https://seekingalpha.com/currents/post/854451\" target=\"_blank\">Q4 report</a>. Data center subsidiary CyrusOne (<a href=\"https://seekingalpha.com/symbol/CONE\" title=\"CyrusOne\">CONE</a> <font color=\"red\">-2.9%</font>), which CBB still owns 71.6% of following a Jan. IPO, is posting more modest losses in response to <a href=\"https://seekingalpha.com/currents/post/853291\" target=\"_blank\">its own report</a>. Excluding Cyrus One, CBB expects 2013 revenue of $1.2B, below a $1.24B consensus. On its <a href=\"https://seekingalpha.com/article/1229761-cincinnati-bell-management-discusses-q4-2012-results-earnings-call-transcript\" target=\"_blank\">earnings call</a>, the telco admitted its wireless ops face \"intense competitive pressures from the national players,\" and that it's becoming harder to offset subscriber losses with cost cuts.</p><div class=\"tiny-share-widget\" data-id=\"855961\" data-linked=\"Poor 2013 guidance has led Cincinnati Bell (CBB -21.3%) to crumble to new 52-week lows following...\" data-tweet=\"$CBB $CBB $CONE - Poor 2013 guidance has led Cincinnati Bell (CBB -21.3%) to crumble to new 52-week lows following its Q4 report. Data center subsidiary CyrusOne (CONE -2.9%), which CBB still owns 71.6% of following a Jan. IPO, is posting more modest lo... https://seekingalpha.com/news/855961?source=tweet\" data-url=\"https://seekingalpha.com/news/855961\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855951\" data-ts=\"1361996665\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRLI\" target=\"_blank\">BRLI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855951\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bio-Reference Labs (BRLI -0.6%) slips on a negative article from short-seller The Street...</a></h4><p>Bio-Reference Labs (<a href=\"https://seekingalpha.com/symbol/BRLI\" title=\"Bio-Reference Laboratories, Inc.\">BRLI</a> <font color=\"red\">-0.6%</font>) slips on a <a href=\"http://thestreetsweeper.org/\" target=\"_blank\">negative article</a> from short-seller The Street Sweeper. The gist of the article says that the company is likely to be faced with a flood of denials from some of the largest health insurance companies in the country, and that growth projections are overly optimistic.</p><div class=\"tiny-share-widget\" data-id=\"855951\" data-linked=\"Bio-Reference Labs (BRLI -0.6%) slips on a negative article from short-seller The Street...\" data-tweet=\"$BRLI - Bio-Reference Labs (BRLI -0.6%) slips on a negative article from short-seller The Street Sweeper. The gist of the article says that the company is likely to be faced with a flood of denials from some of the largest health insurance companies in ... https://seekingalpha.com/news/855951?source=tweet\" data-url=\"https://seekingalpha.com/news/855951\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855931\" data-ts=\"1361995635\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPOR\" target=\"_blank\">GPOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855931\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gulfport Energy (GPOR +8.7%) trades higher today, despite posting a mixed Q4 report yesterday,...</a></h4><p>Gulfport Energy (<a href=\"https://seekingalpha.com/symbol/GPOR\" title=\"Gulfport Energy Corporation\">GPOR</a> <font color=\"green\">+8.7%</font>) trades higher today, despite posting a mixed <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/852981\">Q4 report</a> yesterday, as much-anticipated longer-term production data from its Utica Shale proved better than expected. Sterne Agee says the Utica shale <a target=\"_blank\" href=\"http://finance.yahoo.com/news/gulfport-energy-utica-production-data-141043204.html\">data was bullish</a>, and Q4 earnings per-share beat consensus on a \"strong, albeit messy quarter, with a lot of moving parts.\"</p><div class=\"tiny-share-widget\" data-id=\"855931\" data-linked=\"Gulfport Energy (GPOR +8.7%) trades higher today, despite posting a mixed Q4 report yesterday,...\" data-tweet=\"$GPOR - Gulfport Energy (GPOR +8.7%) trades higher today, despite posting a mixed Q4 report yesterday, as much-anticipated longer-term production data from its Utica Shale proved better than expected. Sterne Agee says the Utica shale data was bullish, a... https://seekingalpha.com/news/855931?source=tweet\" data-url=\"https://seekingalpha.com/news/855931\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855901\" data-ts=\"1361994583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQC\" target=\"_blank\">EQC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855901\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CommonWealth REIT (CWH] -7.8%) is sued by Corvex (Keith Meister) and Related Co. for planning to...</a></h4><p>CommonWealth REIT (<a href=\"https://seekingalpha.com/symbol/CWH\" title=\"Camping World Holdings\">CWH</a>] <font color=\"red\">-7.8%</font>) is <a href=\"http://www.bloomberg.com/news/2013-02-27/meister-related-sue-commonwealth-on-planned-share-sale.html\" target=\"_blank\">sued</a> by Corvex (Keith Meister) and Related Co. for planning to go ahead with a secondary offering despite the duo's $25/share buyout offer (they currently own 9.8% of the shares). <a href=\"http://www.marketfolly.com/2013/02/keith-meisters-corvex-capital-starts.html\" target=\"_blank\">Presentation</a>: Restoring the Health to CommonWealth.</p><div class=\"tiny-share-widget\" data-id=\"855901\" data-linked=\"CommonWealth REIT (CWH] -7.8%) is sued by Corvex (Keith Meister) and Related Co. for planning to...\" data-tweet=\"$EQC - CommonWealth REIT (CWH] -7.8%) is sued by Corvex (Keith Meister) and Related Co. for planning to go ahead with a secondary offering despite the duo&#39;s $25/share buyout offer (they currently own 9.8% of the shares). Presentation: Restoring the Heal... https://seekingalpha.com/news/855901?source=tweet\" data-url=\"https://seekingalpha.com/news/855901\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855891\" data-ts=\"1361994295\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBMX\" target=\"_blank\">CBMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855891\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CombiMatrix (CBMX -21%) gets slammed after reportingg Q4 revenue that was up 18% Y/Y on higher...</a></h4><p>CombiMatrix (<a href=\"https://seekingalpha.com/symbol/CBMX\" title=\"CombiMatrix Corporation\">CBMX</a> <font color=\"red\">-21%</font>) gets slammed after reportingg <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/854141\">Q4 revenue</a> that was up 18% Y/Y on higher revenues from its core prenatal testing markets, which grew by 161% on increased billable test volumes. However, net losses soared on non-cash warrant derivative charges as a result of issuing warrants to certain investors in the Company's Series A Preferred Stock financing.</p><div class=\"tiny-share-widget\" data-id=\"855891\" data-linked=\"CombiMatrix (CBMX -21%) gets slammed after reportingg Q4 revenue that was up 18% Y/Y on higher...\" data-tweet=\"$CBMX - CombiMatrix (CBMX -21%) gets slammed after reportingg Q4 revenue that was up 18% Y/Y on higher revenues from its core prenatal testing markets, which grew by 161% on increased billable test volumes. However, net losses soared on non-cash warrant... https://seekingalpha.com/news/855891?source=tweet\" data-url=\"https://seekingalpha.com/news/855891\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855881\" data-ts=\"1361994285\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBIX\" target=\"_blank\">EBIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855881\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ebix (EBIX +3.5%) has staged a two-day rally since taking part in a Craig-Hallum call (webcast)...</a></h4>Ebix (<a href='https://seekingalpha.com/symbol/EBIX' title='Ebix Inc'>EBIX</a> <font color='green'>+3.5%</font>) has staged a two-day rally since taking part in a Craig-Hallum call (<a href=\"https://www2.eintercall.com/moderator/BroadcastFrame.jsp?server=icexls47&amp;moderator_port=8280&amp;id=d3ce21a7-a3e9-4e59-92fd-98a83ce7eeab.rpm\" target=\"_blank\">webcast</a>) to address what it calls \"materially inaccurate statements and conclusions\" made by SA contributor <a href=\"https://seekingalpha.com/currents/post/842551\" target=\"_blank\">Gotham City Research</a> in a lengthy <a href=\"https://seekingalpha.com/currents/post/842551\" target=\"_blank\">Feb. 21 report</a>. Shares are <font color=\"green\">up 12%</font> from Monday's close, but still <font color=\"red\">down 22%</font> since Gotham's report arrived.<div class=\"tiny-share-widget\" data-id=\"855881\" data-linked=\"Ebix (EBIX +3.5%) has staged a two-day rally since taking part in a Craig-Hallum call (webcast)...\" data-tweet=\"$EBIX - Ebix (EBIX +3.5%) has staged a two-day rally since taking part in a Craig-Hallum call (webcast) to address what it calls &quot;materially inaccurate statements and conclusions&quot; made by SA contributor Gotham City Research in a lengthy Feb. 21 report. ... https://seekingalpha.com/news/855881?source=tweet\" data-url=\"https://seekingalpha.com/news/855881\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855861\" data-ts=\"1361993888\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IP\" target=\"_blank\">IP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855861\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer packaging/containerboard plays International Paper (IP +3.1%) and Rock-Tenn (RKT +2.2%)...</a></h4>Consumer packaging/containerboard plays International Paper (<a href='https://seekingalpha.com/symbol/IP' title='International Paper Co.'>IP</a> <font color='green'>+3.1%</font>) and Rock-Tenn (RKT <font color='green'>+2.2%</font>) outperform after Longbow upgrades shares to Buy. <a href=\"https://seekingalpha.com/currents/post/847851\" target=\"_blank\">JPMorgan</a> upgraded Rock-Tenn on Monday, and <a href=\"https://seekingalpha.com/currents/post/850771\" target=\"_blank\">Jefferies </a>launched coverage on International Paper with a Buy on Tuesday.<div class=\"tiny-share-widget\" data-id=\"855861\" data-linked=\"Consumer packaging/containerboard plays International Paper (IP +3.1%) and Rock-Tenn (RKT +2.2%)...\" data-tweet=\"$IP $IP $WRK - Consumer packaging/containerboard plays International Paper (IP +3.1%) and Rock-Tenn (RKT +2.2%) outperform after Longbow upgrades shares to Buy. JPMorgan upgraded Rock-Tenn on Monday, and Jefferies launched coverage on International Pape... https://seekingalpha.com/news/855861?source=tweet\" data-url=\"https://seekingalpha.com/news/855861\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855851\" data-ts=\"1361993404\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INVN\" target=\"_blank\">INVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855851\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baird has cut InvenSense (INVN -5%) to Neutral on valuation grounds, and that&#39;s producing a...</a></h4><a href=\"http://www.thestreet.com/story/11853835/1/analysts-actions-biib-fslr-goog-lnkd.html?cm_ven=GOOGLEN\" target=\"_blank\">Baird has cut</a> InvenSense (<a href=\"https://seekingalpha.com/symbol/INVN\" title=\"InvenSense\">INVN</a> <font color=\"red\">-5%</font>) to Neutral on valuation grounds, and that's producing a steep selloff on an up day for equities. Earlier this week, the company showed off a 3-axis gyroscope said to offers a smaller form factor than competing products, and a 9-axis motion sensor said to offer superior power consumption. InvenSense <a href=\"https://seekingalpha.com/currents/post/780201\" target=\"_blank\">took off</a> last month following its FQ3 beat.<div class=\"tiny-share-widget\" data-id=\"855851\" data-linked=\"Baird has cut InvenSense (INVN -5%) to Neutral on valuation grounds, and that&#39;s producing a...\" data-tweet=\"$INVN - Baird has cut InvenSense (INVN -5%) to Neutral on valuation grounds, and that&#39;s producing a steep selloff on an up day for equities. Earlier this week, the company showed off a 3-axis gyroscope said to offers a smaller form factor than competing... https://seekingalpha.com/news/855851?source=tweet\" data-url=\"https://seekingalpha.com/news/855851\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855841\" data-ts=\"1361992966\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PDCE\" target=\"_blank\">PDCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855841\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PDC Energy (PDCE +15%) pops after beating Q4 revenue estimates this morning. Net losses came in...</a></h4><p>PDC Energy (<a href=\"https://seekingalpha.com/symbol/PDCE\" title=\"PDC Energy, Inc.\">PDCE</a> <font color=\"green\">+15%</font>) pops after beating <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/854861\">Q4 revenue estimates</a> this morning. Net losses came in below consensus however, due largely to higher exploration and interest expenses. The company also reported better results in the second testing of its Utica shale well, as boe equivelant estimates proved higher than the prior test.</p><div class=\"tiny-share-widget\" data-id=\"855841\" data-linked=\"PDC Energy (PDCE +15%) pops after beating Q4 revenue estimates this morning. Net losses came in...\" data-tweet=\"$PDCE - PDC Energy (PDCE +15%) pops after beating Q4 revenue estimates this morning. Net losses came in below consensus however, due largely to higher exploration and interest expenses. The company also reported better results in the second testing of i... https://seekingalpha.com/news/855841?source=tweet\" data-url=\"https://seekingalpha.com/news/855841\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855811\" data-ts=\"1361991805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNXL\" target=\"_blank\">UNXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855811\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">In-line guidance and plans for an aggressive 2013 output ramp are helping UniPixel (UNXL +22.4%)...</a></h4><p>In-line guidance and plans for an aggressive <a href=\"https://seekingalpha.com/currents/post/853611\" target=\"_blank\">2013 output ramp</a> are helping UniPixel (<a href=\"https://seekingalpha.com/symbol/UNXL\" title=\"Uni-Pixel, Inc.\">UNXL</a> <font color=\"green\">+22.4%</font>) soar to new highs following its <a href=\"https://seekingalpha.com/currents/post/853531\" target=\"_blank\">Q4 report</a>. Also likely helping is a huge short interest - 41.7% of the float was shorted on Jan. 31. On the <a href=\"https://seekingalpha.com/article/1227671-unipixel-ceo-discusses-q4-2012-results-earnings-call-transcript\" target=\"_blank\">earnings call</a>, management said it \"began negotiations last quarter with ecosystem enablers, supply chain and LCD panel manufacturers\" regarding its UniBoss touchscreen film, and has \"received strong interest from OEM and ODMs\" for combining UniBoss with its Diamond Guard protective cover film.</p><div class=\"tiny-share-widget\" data-id=\"855811\" data-linked=\"In-line guidance and plans for an aggressive 2013 output ramp are helping UniPixel (UNXL +22.4%)...\" data-tweet=\"$UNXL - In-line guidance and plans for an aggressive 2013 output ramp are helping UniPixel (UNXL +22.4%) soar to new highs following its Q4 report. Also likely helping is a huge short interest - 41.7% of the float was shorted on Jan. 31. On the earnings... https://seekingalpha.com/news/855811?source=tweet\" data-url=\"https://seekingalpha.com/news/855811\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855801\" data-ts=\"1361991500\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855801\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Sarepta Therapeutics (SRPT +4.1%) pop after Glaxo SmithKline (GSK +0.1%) says that...</a></h4><p>Shares of Sarepta Therapeutics (<a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a> <font color=\"green\">+4.1%</font>) pop after Glaxo SmithKline (<a href=\"https://seekingalpha.com/symbol/GSK\" title=\"GlaxoSmithKline\">GSK</a> <font color=\"green\">+0.1%</font>) says that Duchenne muscular dystrophy patients treated with its experimental drug drisapersen <a target=\"_blank\" href=\"http://www.thestreet.com/story/11854354/1/glaxo-dmd-drug-tied-to-serious-side-effects-hospitalizations.html\">have been hospitalized</a> due to kidney toxicity and low platelet counts. <a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a> is meeting with FDA officials this month to discuss the possibility of an accelerated approval filing for its DMD drug eteplirsen based on a completed phase II study. Eteplirsen's adverse event reports have been relatively unblemished to date.</p><div class=\"tiny-share-widget\" data-id=\"855801\" data-linked=\"Shares of Sarepta Therapeutics (SRPT +4.1%) pop after Glaxo SmithKline (GSK +0.1%) says that...\" data-tweet=\"$SRPT $SRPT $GSK - Shares of Sarepta Therapeutics (SRPT +4.1%) pop after Glaxo SmithKline (GSK +0.1%) says that Duchenne muscular dystrophy patients treated with its experimental drug drisapersen have been hospitalized due to kidney toxicity and low pla... https://seekingalpha.com/news/855801?source=tweet\" data-url=\"https://seekingalpha.com/news/855801\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855771\" data-ts=\"1361990125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIO\" target=\"_blank\">BIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855771\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Bio-Rad (BIO +5%) move higher today after a solid Q4 earnings beat. Total sales rose...</a></h4><p>Shares of Bio-Rad (<a href=\"https://seekingalpha.com/symbol/BIO\" title=\"Bio-Rad Laboratories, Inc.\">BIO</a> <font color=\"green\">+5%</font>) move higher today after a solid <a href=\"https://seekingalpha.com/market_currents/post/853101\" target=\"_blank\">Q4 earnings</a> beat. Total sales rose 4.3% Y/Y, which was offset somewhat by a decline in gross margin to 55.9% from 56.5%. Sidoti <a href=\"http://www.streetinsider.com/Upgrades/Sidoti+Upgrades+Bio-Rad+Labs+%28BIO%29+to+Buy/8137900.html\" target=\"_blank\">upgrades the stock</a> to Buy on the back of the upbeat report, while Jefferies <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/02/3373152/update-jefferies-reiterates-buy-rating-raises-pt-on-bio-\" target=\"_blank\">ups its price target</a> to $140 from $124 on higher cash flow forecasts.</p><div class=\"tiny-share-widget\" data-id=\"855771\" data-linked=\"Shares of Bio-Rad (BIO +5%) move higher today after a solid Q4 earnings beat. Total sales rose...\" data-tweet=\"$BIO - Shares of Bio-Rad (BIO +5%) move higher today after a solid Q4 earnings beat. Total sales rose 4.3% Y/Y, which was offset somewhat by a decline in gross margin to 55.9% from 56.5%. Sidoti upgrades the stock to Buy on the back of the upbeat report... https://seekingalpha.com/news/855771?source=tweet\" data-url=\"https://seekingalpha.com/news/855771\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855751\" data-ts=\"1361989532\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMPE\" target=\"_blank\">AMPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855751\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ampio Pharmaceuticals (AMPE +4%) trades up after announcing its begun dosing the first patient...</a></h4><p>Ampio Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/AMPE\" title=\"Ampio Pharmaceuticals, Inc.\">AMPE</a> <font color=\"green\">+4%</font>) trades up after announcing its begun dosing the first patient in its clinical trial of Optina, a treatment for diabetic macular edema. The trial will evaluate the drug in adults with recent onset of the disease. Last year, the FDA granted Optina 505(b)(2) status. Drugs under this designated pathway can be approved on a single trial.</p><div class=\"tiny-share-widget\" data-id=\"855751\" data-linked=\"Ampio Pharmaceuticals (AMPE +4%) trades up after announcing its begun dosing the first patient...\" data-tweet=\"$AMPE - Ampio Pharmaceuticals (AMPE +4%) trades up after announcing its begun dosing the first patient in its clinical trial of Optina, a treatment for diabetic macular edema. The trial will evaluate the drug in adults with recent onset of the disease. ... https://seekingalpha.com/news/855751?source=tweet\" data-url=\"https://seekingalpha.com/news/855751\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855731\" data-ts=\"1361988779\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COP\" target=\"_blank\">COP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855731\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canada&#39;s Canacol (CAAEF.PK&amp;nbsp;+5%) finds another partner for shale oil exploration in...</a></h4>Canada's Canacol (CAAEF.PK&nbsp;<font color=\"green\">+5%</font>) finds <a href=\"http://online.wsj.com/article/SB10001424127887323478304578330131373531600.html?ru=yahoo&amp;mod=yahoo_hs\" target=\"_blank\">another partner</a> for shale oil exploration in Colombia, with ConocoPhillips (NYSE:<a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a>) agreeing to pay the cost of drilling and testing as many as 13 wells in exchange for 70% of the oil found in the deeper areas.<div class=\"tiny-share-widget\" data-id=\"855731\" data-linked=\"Canada&#39;s Canacol (CAAEF.PK&amp;nbsp;+5%) finds another partner for shale oil exploration in...\" data-tweet=\"$COP $CNNEF - Canada&#39;s Canacol (CAAEF.PK&amp;nbsp;+5%) finds another partner for shale oil exploration in Colombia, with ConocoPhillips (NYSE:COP) agreeing to pay the cost of drilling and testing as many as 13 wells in exchange for 70% of the oil found in t... https://seekingalpha.com/news/855731?source=tweet\" data-url=\"https://seekingalpha.com/news/855731\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855681\" data-ts=\"1361987711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZGNX\" target=\"_blank\">ZGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855681\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers: ZGNX +39%. UNXL +24%. FSGI +21%. GWRE +18%. ELMD +16%. PDCE +14%. OPTR...</a></h4><b>Midday top 10 gainers:</b> <a href=\"https://seekingalpha.com/symbol/ZGNX\" title=\"Zogenix, Inc.\">ZGNX</a> <font color=\"green\">+39%</font>. <a href=\"https://seekingalpha.com/symbol/UNXL\" title=\"Uni-Pixel, Inc.\">UNXL</a> <font color=\"green\">+24%</font>. <a href=\"https://seekingalpha.com/symbol/FSGI\" title=\"First Security Group, Inc.\">FSGI</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/GWRE\" title=\"Guidewire Software, Inc.\">GWRE</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/ELMD\" title=\"Electromed, Inc.\">ELMD</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/PDCE\" title=\"PDC Energy, Inc.\">PDCE</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/OPTR\" title=\"Optimer Pharmaceuticals, Inc.\">OPTR</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/DLTR\" title=\"Dollar Tree, Inc.\">DLTR</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/END\" title=\"Endeavour International Corporation\">END</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/SHI\" title=\"Sinopec Shanghai Petrochemical Company Limited\">SHI</a> <font color=\"green\">+11%</font>.<br> <b>Midday top 10 losers:</b> AH <font color=\"red\">-26%</font>. <a href=\"https://seekingalpha.com/symbol/CBB\" title=\"Cincinnati Bell Inc.\">CBB</a> <font color=\"red\">-23%</font>. <a href=\"https://seekingalpha.com/symbol/AMBO\" title=\"Ambow Education Holding Ltd.\">AMBO</a> <font color=\"red\">-22%</font>. RNIN <font color=\"red\">-21%</font>. <a href=\"https://seekingalpha.com/symbol/CBMX\" title=\"CombiMatrix Corporation\">CBMX</a> <font color=\"red\">-19%</font>. <a href=\"https://seekingalpha.com/symbol/XWES\" title=\"World Energy Solutions Inc\">XWES</a> <font color=\"red\">-19%</font>. <a href=\"https://seekingalpha.com/symbol/FSLR\" title=\"First Solar, Inc.\">FSLR</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/CMGE\" title=\"China Mobile Games &amp; Entertainment Group Ltd\">CMGE</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/CRMB\" title=\"Crumbs Bake Shop, Inc\">CRMB</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/PRPH\" title=\"ProPhase Labs, Inc.\">PRPH</a> <font color=\"red\">-12%</font>.<div class=\"tiny-share-widget\" data-id=\"855681\" data-linked=\"Midday top 10 gainers: ZGNX +39%. UNXL +24%. FSGI +21%. GWRE +18%. ELMD +16%. PDCE +14%. OPTR...\" data-tweet=\"$ZGNX $ZGNX $UNXL - Midday top 10 gainers: ZGNX +39%. UNXL +24%. FSGI +21%. GWRE +18%. ELMD +16%. PDCE +14%. OPTR +13%. DLTR +12%. END +11%. SHI +11%. Midday top 10 losers: AH -26%. CBB -23%. AMBO -22%. RNIN -21%. CBMX -19%. XWES -19%. FSLR -16%. CMGE -... https://seekingalpha.com/news/855681?source=tweet\" data-url=\"https://seekingalpha.com/news/855681\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855671\" data-ts=\"1361986939\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAKO\" target=\"_blank\">MAKO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855671\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Mako Surgical (MAKO +10.9%) surge despite a Q4 miss late yesterday, as the company...</a></h4><p>Shares of Mako Surgical (<a href=\"https://seekingalpha.com/symbol/MAKO\" title=\"MAKO Surgical Corp.\">MAKO</a> <font color=\"green\">+10.9%</font>) surge despite a <a href=\"https://seekingalpha.com/market_currents/post/835391\" target=\"_blank\">Q4 miss</a> late yesterday, as the company forecasts higher sales of its RIO systems in the coming year with a corresponding 24% to 42% jump in surgical procedures.</p><div class=\"tiny-share-widget\" data-id=\"855671\" data-linked=\"Shares of Mako Surgical (MAKO +10.9%) surge despite a Q4 miss late yesterday, as the company...\" data-tweet=\"$MAKO - Shares of Mako Surgical (MAKO +10.9%) surge despite a Q4 miss late yesterday, as the company forecasts higher sales of its RIO systems in the coming year with a corresponding 24% to 42% jump in surgical procedures. https://seekingalpha.com/news/855671?source=tweet\" data-url=\"https://seekingalpha.com/news/855671\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855641\" data-ts=\"1361986574\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STWD\" target=\"_blank\">STWD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855641\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Starwood Property Trust (STWD +4.2%) following its big earnings beat. The company put another...</a></h4><p>Starwood Property Trust (<a href=\"https://seekingalpha.com/symbol/STWD\" title=\"Starwood Property Trust, Inc.\">STWD</a> <font color=\"green\">+4.2%</font>) following its <a href=\"https://seekingalpha.com/currents/post/854221\" target=\"_blank\">big earnings beat</a>. The company put another $1B to work in Q4, bringing 2012's total to $2.6B. Assets held for investment sum to $3.4B with annualized levered return of 11.7%-12.2% expected over their life. \"CMBS originators appear to be in a sweet spot,\" <a href=\"https://twitter.com/Talkot/status/306815483271847936\" target=\"_blank\">says</a> Dynex (NYSE:<a href=\"https://seekingalpha.com/symbol/DX\" title=\"Dynex Capital Inc.\">DX</a>) CEO Tom Akin, looking forward to Walker &amp; Dunlop's (NYSE:<a href=\"https://seekingalpha.com/symbol/WD\" title=\"Walker &amp; Dunlop, Inc.\">WD</a>) report next week.</p><div class=\"tiny-share-widget\" data-id=\"855641\" data-linked=\"Starwood Property Trust (STWD +4.2%) following its big earnings beat. The company put another...\" data-tweet=\"$STWD $STWD $DX - Starwood Property Trust (STWD +4.2%) following its big earnings beat. The company put another $1B to work in Q4, bringing 2012&#39;s total to $2.6B. Assets held for investment sum to $3.4B with annualized levered return of 11.7%-12.2% expe... https://seekingalpha.com/news/855641?source=tweet\" data-url=\"https://seekingalpha.com/news/855641\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855631\" data-ts=\"1361985791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AFFY\" target=\"_blank\">AFFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855631\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The dead-cat bounce continues for another day in Affymax (OTC:AFFY +6.3%) after Monday&#39;s -85%...</a></h4>The dead-cat bounce continues for another day in Affymax (<a href='https://seekingalpha.com/symbol/AFFY' title='Affymax, Inc.'>OTC:AFFY</a> <font color=\"green\">+6.3%</font>) after Monday's <font color=\"red\">-85%</font>  plummet. The stock has gained over <font color=\"green\">13%</font> since cratering on the news of its <a href=\"https://seekingalpha.com/market_currents/post/847951\" target=\"_blank\">Omontys recall</a>, but without any real catalysts to drive the stock over the near-term, it's doubtful that the move has any real substance.<div class=\"tiny-share-widget\" data-id=\"855631\" data-linked=\"The dead-cat bounce continues for another day in Affymax (OTC:AFFY +6.3%) after Monday&#39;s -85%...\" data-tweet=\"$AFFY - The dead-cat bounce continues for another day in Affymax (OTC:AFFY +6.3%) after Monday&#39;s -85% plummet. The stock has gained over 13% since cratering on the news of its Omontys recall, but without any real catalysts to drive the stock over the ne... https://seekingalpha.com/news/855631?source=tweet\" data-url=\"https://seekingalpha.com/news/855631\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855561\" data-ts=\"1361984098\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNOV\" target=\"_blank\">MNOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855561\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MediciNova (NASDAQ:MNOV) tacks on an additional 12.4% gain from yesterday&#39;s big move, after the...</a></h4>MediciNova (NASDAQ:<a href='https://seekingalpha.com/symbol/MNOV' title='MediciNova, Inc.'>MNOV</a>) tacks on an additional <font color=\"green\">12.4%</font> gain from yesterday's big move, after the company said its MN-166 drug treatment for methamphetamine dependence has been granted f<a href=\"https://seekingalpha.com/market_currents/post/851661\" target=\"_blank\">ast-track status</a> by the FDA.<div class=\"tiny-share-widget\" data-id=\"855561\" data-linked=\"MediciNova (NASDAQ:MNOV) tacks on an additional 12.4% gain from yesterday&#39;s big move, after the...\" data-tweet=\"$MNOV - MediciNova (NASDAQ:MNOV) tacks on an additional 12.4% gain from yesterday&#39;s big move, after the company said its MN-166 drug treatment for methamphetamine dependence has been granted fast-track status by the FDA. https://seekingalpha.com/news/855561?source=tweet\" data-url=\"https://seekingalpha.com/news/855561\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855541\" data-ts=\"1361983245\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSLR\" target=\"_blank\">FSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855541\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Unsurprisingly, solar stocks are giving back some of their big 2013 gains (TAN -3.7%) in...</a></h4><p>Unsurprisingly, solar stocks are giving back some of their big 2013 gains (<a href=\"https://seekingalpha.com/symbol/TAN\" title=\"Invesco Solar Portfolio ETF\">TAN</a> <font color=\"red\">-3.7%</font>) in response to First Solar's (<a href=\"https://seekingalpha.com/symbol/FSLR\" title=\"First Solar, Inc.\">FSLR</a> <font color=\"red\">-16.1%</font>) <a href=\"https://seekingalpha.com/currents/post/852971\" target=\"_blank\">Q4 results</a> and guidance. <a href=\"https://seekingalpha.com/symbol/LDK\" title=\"LDK Solar Co., Ltd.\">LDK</a> <font color=\"red\">-9.6%</font>. SCTY <font color=\"red\">-7.7%</font>. <a href=\"https://seekingalpha.com/symbol/SPWR\" title=\"SunPower Corporation\">SPWR</a> <font color=\"red\">-6.2%</font>. <a href=\"https://seekingalpha.com/symbol/YGE\" title=\"Yingli Green Energy Holding Company Limited\">YGE</a> <font color=\"red\">-6%</font>. <a href=\"https://seekingalpha.com/symbol/TSL\" title=\"Trina Solar Limited\">TSL</a> <font color=\"red\">-4.5%</font>. <a href=\"https://seekingalpha.com/symbol/JASO\" title=\"JA Solar Holdings, Co., Ltd.\">JASO</a> <font color=\"red\">-4.4%</font>. GTAT <font color=\"red\">-2.9%</font>. Piper and Baird have joined <a href=\"https://seekingalpha.com/currents/post/854491\" target=\"_blank\">BofA</a> in downgrading FSLR. On the <a href=\"https://seekingalpha.com/article/1227281-first-solar-s-ceo-discusses-q4-2012-results-earnings-call-transcript?part=single\" target=\"_blank\">earnings call</a>, management said it's targeting a 2013 book-to-bill of at least 1 (it was 0.8 in 2012), but cautioned it expects 2H results to be weaker than 1H results due to upcoming project completions and a greater mix of module sales.</p><div class=\"tiny-share-widget\" data-id=\"855541\" data-linked=\"Unsurprisingly, solar stocks are giving back some of their big 2013 gains (TAN -3.7%) in...\" data-tweet=\"$FSLR $TAN $FSLR - Unsurprisingly, solar stocks are giving back some of their big 2013 gains (TAN -3.7%) in response to First Solar&#39;s (FSLR -16.1%) Q4 results and guidance. LDK -9.6%. SCTY -7.7%. SPWR -6.2%. YGE -6%. TSL -4.5%. JASO -4.4%. GTAT -2.9%. P... https://seekingalpha.com/news/855541?source=tweet\" data-url=\"https://seekingalpha.com/news/855541\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855471\" data-ts=\"1361981806\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PZZA\" target=\"_blank\">PZZA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855471\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Papa John&#39;s (PZZA -8%) slumps after missing earnings estimates with its Q4 report and restating...</a></h4>Papa John's (<a href='https://seekingalpha.com/symbol/PZZA' title='Papa John&#39;s International, Inc.'>PZZA</a> <font color='red'>-8%</font>) slumps after <a href=\"https://seekingalpha.com/currents/post/853851\" target=\"_blank\">missing</a> earnings estimates with its Q4 report and <a href=\"https://seekingalpha.com/currents/post/853701\" target=\"_blank\">restating</a> financial results from 2009 to 2011. During the latest quarter, the company saw global sales growth of 19.6% and growth at restaurants opened at least a year of 7%.<div class=\"tiny-share-widget\" data-id=\"855471\" data-linked=\"Papa John&#39;s (PZZA -8%) slumps after missing earnings estimates with its Q4 report and restating...\" data-tweet=\"$PZZA - Papa John&#39;s (PZZA -8%) slumps after missing earnings estimates with its Q4 report and restating financial results from 2009 to 2011. During the latest quarter, the company saw global sales growth of 19.6% and growth at restaurants opened at leas... https://seekingalpha.com/news/855471?source=tweet\" data-url=\"https://seekingalpha.com/news/855471\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855461\" data-ts=\"1361981535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDMO\" target=\"_blank\">CDMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855461\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Peregrine Pharmaceuticals (PPHM +8.7%) regains some yesterday&#39;s decline after the company was...</a></h4><p>Peregrine Pharmaceuticals (PPHM <font color=\"green\">+8.7%</font>) regains some yesterday's decline after the company was featured in a <a href=\"https://seekingalpha.com/article/1223751-peregrine-pharmaceuticals-bavituximab-it-s-time-to-throw-in-the-towel\" target=\"_blank\">pessimistic article</a> in Seeking Alpha. The stock actually began its fall on Monday, but was exacerbated yesterday by the SA piece by contributor Robert Schwartz, who noted that PPHM's lead drug candidate, bavituximab, has had twelve Phase-I/-II studies and treated 613 cancer patients but has yet to observe a statistically significant improvement over a contemporary standard-of-care. Schwartz thinks its time to throw in the towel.</p><div class=\"tiny-share-widget\" data-id=\"855461\" data-linked=\"Peregrine Pharmaceuticals (PPHM +8.7%) regains some yesterday&#39;s decline after the company was...\" data-tweet=\"$CDMO - Peregrine Pharmaceuticals (PPHM +8.7%) regains some yesterday&#39;s decline after the company was featured in a pessimistic article in Seeking Alpha. The stock actually began its fall on Monday, but was exacerbated yesterday by the SA piece by contr... https://seekingalpha.com/news/855461?source=tweet\" data-url=\"https://seekingalpha.com/news/855461\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855401\" data-ts=\"1361980161\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZGNX\" target=\"_blank\">ZGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855401\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zogenix (ZGNX +44%) continues to surge higher this morning on the news of the FDA decision to...</a></h4><p>Zogenix (<a href=\"https://seekingalpha.com/symbol/ZGNX\" title=\"Zogenix, Inc.\">ZGNX</a> <font color=\"green\">+44%</font>) continues to surge higher this morning on the news of the <a href=\"https://seekingalpha.com/market_currents/post/854791\" target=\"_blank\">FDA decision</a> to push back its PDUFA date for Zohydro. Analysts see the delay as a <a href=\"http://www.streetinsider.com/Trader+Talk/Zogenix+%28ZGNX%29+Surges+Despite+PDUFA+Delay%3B+Analysts+View+Positively+/8137716.html\" target=\"_blank\">potential positive</a>, as it's likely to be short-lived and the odds for eventual approval are still high. Wells Fargo's Michael Tong sees just 20% downside on a negative FDA decision but potentially 100%+ upside for the stock if given the green light.</p><div class=\"tiny-share-widget\" data-id=\"855401\" data-linked=\"Zogenix (ZGNX +44%) continues to surge higher this morning on the news of the FDA decision to...\" data-tweet=\"$ZGNX - Zogenix (ZGNX +44%) continues to surge higher this morning on the news of the FDA decision to push back its PDUFA date for Zohydro. Analysts see the delay as a potential positive, as it&#39;s likely to be short-lived and the odds for eventual approv... https://seekingalpha.com/news/855401?source=tweet\" data-url=\"https://seekingalpha.com/news/855401\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855341\" data-ts=\"1361979563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BGMD\" target=\"_blank\">BGMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855341\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BG Medicine (OTC:BGMD +11%) ramps higher this morning after announcing the publication of two...</a></h4><p>BG Medicine (<a href=\"https://seekingalpha.com/symbol/BGMD\" title=\"BG Medicine, Inc.\">OTC:BGMD</a> <font color=\"green\">+11%</font>) ramps higher this morning after announcing the publication of two studies demonstrating the benefit of repeated galectin-3 testing as a tool in the assessment of patients with heart failure. The studies demonstrate that periodic evaluation of galectin-3 levels can help clinicians identify those at greater risk of unplanned hospital admission and cardiovascular morbidity and mortality.</p><div class=\"tiny-share-widget\" data-id=\"855341\" data-linked=\"BG Medicine (OTC:BGMD +11%) ramps higher this morning after announcing the publication of two...\" data-tweet=\"$BGMD - BG Medicine (OTC:BGMD +11%) ramps higher this morning after announcing the publication of two studies demonstrating the benefit of repeated galectin-3 testing as a tool in the assessment of patients with heart failure. The studies demonstrate th... https://seekingalpha.com/news/855341?source=tweet\" data-url=\"https://seekingalpha.com/news/855341\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855331\" data-ts=\"1361979168\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPX\" target=\"_blank\">TPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855331\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tempur-Pedic (TPX +7.2%) and Select Comfort (SCSS +2.2%) trade higher after KeyBanc says...</a></h4><p>Tempur-Pedic (<a href=\"https://seekingalpha.com/symbol/TPX\" title=\"Tempur Sealy International Inc.\">TPX</a> <font color=\"green\">+7.2%</font>) and Select Comfort (SCSS <font color=\"green\">+2.2%</font>) trade higher after KeyBanc says mattress sales <a href=\"http://www.theflyonthewall.com/permalinks/entry.php\" target=\"_blank\">accelerated</a> in January. The mattress sector is viewed as more susceptible than most to pressure on middle-income consumers.</p><div class=\"tiny-share-widget\" data-id=\"855331\" data-linked=\"Tempur-Pedic (TPX +7.2%) and Select Comfort (SCSS +2.2%) trade higher after KeyBanc says...\" data-tweet=\"$TPX $TPX $SNBR - Tempur-Pedic (TPX +7.2%) and Select Comfort (SCSS +2.2%) trade higher after KeyBanc says mattress sales accelerated in January. The mattress sector is viewed as more susceptible than most to pressure on middle-income consumers. https://seekingalpha.com/news/855331?source=tweet\" data-url=\"https://seekingalpha.com/news/855331\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855321\" data-ts=\"1361979068\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPTR\" target=\"_blank\">OPTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855321\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Optimer Pharmaceuticals (OPTR +15%) says its board of directors has begun exploring a full range...</a></h4><p>Optimer Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/OPTR\" title=\"Optimer Pharmaceuticals, Inc.\">OPTR</a> <font color=\"green\">+15%</font>) says its board of directors has begun exploring a full range of strategic alternatives and has engaged JPMorgan and Centerview Partners as financial advisers. The board stated however, that there are no assurances that the review will result in any action and that there would be no further comment on the process until it's completed. The company also preannounced <a href=\"https://seekingalpha.com/market_currents/post/845811\" target=\"_blank\">Q4 results</a> of $0.02 per share, and appointed its chairman, Dr. Henry McKinnell, as CEO.</p><div class=\"tiny-share-widget\" data-id=\"855321\" data-linked=\"Optimer Pharmaceuticals (OPTR +15%) says its board of directors has begun exploring a full range...\" data-tweet=\"$OPTR - Optimer Pharmaceuticals (OPTR +15%) says its board of directors has begun exploring a full range of strategic alternatives and has engaged JPMorgan and Centerview Partners as financial advisers. The board stated however, that there are no assura... https://seekingalpha.com/news/855321?source=tweet\" data-url=\"https://seekingalpha.com/news/855321\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855291\" data-ts=\"1361978817\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIG\" target=\"_blank\">FIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855291\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Fortress Investment (NYSE:FIG) Q4 earnings: Buy low - the company in 2012 repurchased...</a></h4><p>More on Fortress Investment (NYSE:<a href=\"https://seekingalpha.com/symbol/FIG\" title=\"Fortress Investment Group LLC\">FIG</a>) Q4 <a href=\"https://seekingalpha.com/currents/post/854391\" target=\"_blank\">earnings</a>: Buy low - the company in 2012 repurchased 10% of its shares at $3.50 each vs. current price of $6.40. New commitments of $1.6B in 2013 thus far vs. $6.7B for all 2012. \"Dry powder\" of $6.2B vs. total AUM of $53.4B. \"The credit environment worldwide stinks right now,\" says management on the <a href=\"http://shareholders.fortress.com/GenPage.aspx?IID=4147324&amp;GKP=1073747737\" target=\"_blank\">conference call</a>(company <a href=\"https://seekingalpha.com/currents/post/854541\" target=\"_blank\">hiked dividend</a> today). Shares<font color=\"green\"> +2.4%</font> today,<font color=\"green\"> +45%</font> YTD.</p><div class=\"tiny-share-widget\" data-id=\"855291\" data-linked=\"More on Fortress Investment (NYSE:FIG) Q4 earnings: Buy low - the company in 2012 repurchased...\" data-tweet=\"$FIG - More on Fortress Investment (NYSE:FIG) Q4 earnings: Buy low - the company in 2012 repurchased 10% of its shares at $3.50 each vs. current price of $6.40. New commitments of $1.6B in 2013 thus far vs. $6.7B for all 2012. &quot;Dry powder&quot; of $6.2B vs. ... https://seekingalpha.com/news/855291?source=tweet\" data-url=\"https://seekingalpha.com/news/855291\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855281\" data-ts=\"1361978053\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855281\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Following Nokia&#39;s (NOK +3.9%) Mobile World Congress Lumia and feature phone launches, Argus is...</a></h4><p>Following Nokia's (<a href=\"https://seekingalpha.com/symbol/NOK\" title=\"Nokia Corporation\">NOK</a> <font color=\"green\">+3.9%</font>) Mobile World Congress <a href=\"https://seekingalpha.com/currents/post/848831\" target=\"_blank\">Lumia</a> and <a href=\"https://seekingalpha.com/currents/post/850101\" target=\"_blank\">feature phone </a>launches, Argus is now more optimistic about the company's low-end and mid-range prospects, and has <a href=\"http://blogs.barrons.com/techtraderdaily/2013/02/27/this-morning-aapl-shareholder-meeting-in-focus-another-goog-upgrade/\" target=\"_blank\">upgraded shares to Buy</a>. That's leading Nokia to rally after closing yesterday <a href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1361566800000&amp;chddm=14889&amp;chls=IntervalBasedLine&amp;q=NYSE:NOK&amp;ntsp=0&amp;ei=MSEuUdiVC4e2iALy8wE\" target=\"_blank\">near its 2013 lows</a>.</p><div class=\"tiny-share-widget\" data-id=\"855281\" data-linked=\"Following Nokia&#39;s (NOK +3.9%) Mobile World Congress Lumia and feature phone launches, Argus is...\" data-tweet=\"$NOK - Following Nokia&#39;s (NOK +3.9%) Mobile World Congress Lumia and feature phone launches, Argus is now more optimistic about the company&#39;s low-end and mid-range prospects, and has upgraded shares to Buy. That&#39;s leading Nokia to rally after closing ye... https://seekingalpha.com/news/855281?source=tweet\" data-url=\"https://seekingalpha.com/news/855281\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855271\" data-ts=\"1361977933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KSU\" target=\"_blank\">KSU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855271\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Railroad stocks move higher after a report on durable goods comes in better than expected with...</a></h4>Railroad stocks move higher after a <a href=\"https://seekingalpha.com/currents/post/854831\" target=\"_blank\">report</a> on durable goods comes in better than expected with Kansas City Southern (<a href='https://seekingalpha.com/symbol/KSU' title='Kansas City Southern'>KSU</a> <font color='green'>+6.4%</font>) leading the pack. Advancers: <a href='https://seekingalpha.com/symbol/UNP' title='Union Pacific Corporation'>UNP</a> <font color=\"green\">+2.0%</font>, <a href='https://seekingalpha.com/symbol/GWR' title='Genesee & Wyoming, Inc.'>GWR</a> <font color=\"green\">+2.2%</font>, <a href='https://seekingalpha.com/symbol/CNI' title='Canadian National Railway Company'>CNI</a> <font color=\"green\">+1.6%</font>, <a href='https://seekingalpha.com/symbol/UNP' title='Union Pacific Corporation'>UNP</a> <font color=\"green\">+2.1%</font>.<div class=\"tiny-share-widget\" data-id=\"855271\" data-linked=\"Railroad stocks move higher after a report on durable goods comes in better than expected with...\" data-tweet=\"$KSU $KSU $UNP - Railroad stocks move higher after a report on durable goods comes in better than expected with Kansas City Southern (KSU +6.4%) leading the pack. Advancers: UNP +2.0%, GWR +2.2%, CNI +1.6%, UNP +2.1%. https://seekingalpha.com/news/855271?source=tweet\" data-url=\"https://seekingalpha.com/news/855271\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855261\" data-ts=\"1361977812\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFT\" target=\"_blank\">WFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855261\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weatherford International (WFT -2.8%) slips after reporting a better-than-expected Q4, with...</a></h4><p>Weatherford International (<a href=\"https://seekingalpha.com/symbol/WFT\" title=\"Weatherford International Ltd.\">WFT</a> <font color=\"red\">-2.8%</font>) slips after reporting a better-than-expected Q4, with total sales topping consensus estimates. Despite that, net losses widened as the oilfield-services company posted $122M in special charges related to its South American operations, which offset record revenue for the period. The company also gave a tepid view for FY13, maintaining a neutral outlook for its North American business and expecting only modest revenue and operating income growth.</p><div class=\"tiny-share-widget\" data-id=\"855261\" data-linked=\"Weatherford International (WFT -2.8%) slips after reporting a better-than-expected Q4, with...\" data-tweet=\"$WFT $WFTIQ - Weatherford International (WFT -2.8%) slips after reporting a better-than-expected Q4, with total sales topping consensus estimates. Despite that, net losses widened as the oilfield-services company posted $122M in special charges related ... https://seekingalpha.com/news/855261?source=tweet\" data-url=\"https://seekingalpha.com/news/855261\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855231\" data-ts=\"1361977562\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAM\" target=\"_blank\">BAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855231\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Downgrades from Goldman and JPMorgan are leading GrafTech (GTI -8%) to tumble for the second day...</a></h4><p>Downgrades from Goldman and JPMorgan are leading GrafTech (GTI <font color=\"red\">-8%</font>) to tumble for the second day in a row. <a href=\"http://www.streetinsider.com/Downgrades/Goldman+Sachs+Downgrades+GrafTech+International+%28GTI%29+to+Sell/8136513.html\" target=\"_blank\">Goldman</a>, which is lowering shares to Sell and slashing 2013/2014 EPS estimates: \"We expect oversupply in the electrode market to worsen in the foreseeable future as new capacity continues to be built, both in China and ex-China.\" GrafTech <a href=\"https://seekingalpha.com/currents/post/852791\" target=\"_blank\">fell yesterday</a> in response to the guidance provided with its <a href=\"https://seekingalpha.com/currents/post/850891\" target=\"_blank\">Q4 beat</a>.</p><div class=\"tiny-share-widget\" data-id=\"855231\" data-linked=\"Downgrades from Goldman and JPMorgan are leading GrafTech (GTI -8%) to tumble for the second day...\" data-tweet=\"$BAM - Downgrades from Goldman and JPMorgan are leading GrafTech (GTI -8%) to tumble for the second day in a row. Goldman, which is lowering shares to Sell and slashing 2013/2014 EPS estimates: &quot;We expect oversupply in the electrode market to worsen in ... https://seekingalpha.com/news/855231?source=tweet\" data-url=\"https://seekingalpha.com/news/855231\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855181\" data-ts=\"1361976865\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855181\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LinkedIn (LNKD +3.1%) and OpenTable (OPEN +3.8%) jump out of the gate after Wunderlich starts...</a></h4>LinkedIn (LNKD <font color=\"green\">+3.1%</font>) and OpenTable (<a href='https://seekingalpha.com/symbol/OPEN' title='OpenTable, Inc.'>OPEN</a> <font color=\"green\">+3.8%</font>) jump out of the gate after Wunderlich starts coverage with Buy ratings. Also, Evercore's Ken Sena has <a target=\"_blank\" href=\"http://www.forbes.com/sites/ericsavitz/2013/02/27/linkedin-evercore-pounds-the-table-ups-target-to-200/\">raised his PT</a> for LinkedIn to $200 from $160, arguing it should trade at multiples comparable to those of cloud software plays Workday and ServiceNow, and that of Salesforce shortly after its IPO (<em>ed:</em> the valuations of those firms have been <a target=\"_blank\" href=\"https://seekingalpha.com/currents/search?query=wday%20valuation\">criticized</a>). Sena' reasoning: LinkedIn's subscription streams, addressable markets, and margin leverage \"renders traditional earnings valuation metrics less meaningful.\"<div class=\"tiny-share-widget\" data-id=\"855181\" data-linked=\"LinkedIn (LNKD +3.1%) and OpenTable (OPEN +3.8%) jump out of the gate after Wunderlich starts...\" data-tweet=\"$MSFT $MSFT $OPEN - LinkedIn (LNKD +3.1%) and OpenTable (OPEN +3.8%) jump out of the gate after Wunderlich starts coverage with Buy ratings. Also, Evercore&#39;s Ken Sena has raised his PT for LinkedIn to $200 from $160, arguing it should trade at multiples... https://seekingalpha.com/news/855181?source=tweet\" data-url=\"https://seekingalpha.com/news/855181\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855171\" data-ts=\"1361976658\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DG\" target=\"_blank\">DG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855171\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dollar General (DG +4.5%) and Family Dollar (FDO +3.4%) move higher after peer Dollar Tree (DLTR...</a></h4><p>Dollar General (<a href=\"https://seekingalpha.com/symbol/DG\" title=\"Dollar General Corporation\">DG</a> <font color=\"green\">+4.5%</font>) and Family Dollar (<a href=\"https://seekingalpha.com/symbol/FDO\" title=\"Family Dollar Stores Inc.\">FDO</a> <font color=\"green\">+3.4%</font>) move higher after peer Dollar Tree (<a href=\"https://seekingalpha.com/symbol/DLTR\" title=\"Dollar Tree, Inc.\">DLTR</a> <font color=\"green\">+8.9%</font>) posts a <a href=\"https://seekingalpha.com/currents/post/854511\" target=\"_blank\">better-than-expected quarterly profit</a>. Expectations for the discounter group were set lower when Wal-Mart warned on February sales, but <a href=\"https://seekingalpha.com/currents/post/854601\" target=\"_blank\">stability</a> from Dollar Tree appears to be tipping sentiment back in the other direction.</p><div class=\"tiny-share-widget\" data-id=\"855171\" data-linked=\"Dollar General (DG +4.5%) and Family Dollar (FDO +3.4%) move higher after peer Dollar Tree (DLTR...\" data-tweet=\"$DG $DG $FDO - Dollar General (DG +4.5%) and Family Dollar (FDO +3.4%) move higher after peer Dollar Tree (DLTR +8.9%) posts a better-than-expected quarterly profit. Expectations for the discounter group were set lower when Wal-Mart warned on February s... https://seekingalpha.com/news/855171?source=tweet\" data-url=\"https://seekingalpha.com/news/855171\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855071\" data-ts=\"1361975127\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855071\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clearwire (CLWR) -2.5% after confirming it&#39;s tapping $80M in financing provided by Sprint...</a></h4><p>Clearwire (<a href=\"https://seekingalpha.com/symbol/CLWR\" title=\"\">CLWR</a>) <font color=\"red\">-2.5%</font> after confirming it's tapping $80M in financing provided by Sprint (NYSE:<a href=\"https://seekingalpha.com/symbol/S\" title=\"Sprint Corporation\">S</a>); it consists of debt that could be exchanged into Clearwire stock at $1.50/share in the future. The 4G network owner says it hasn't decided whether to take additional financing from Sprint, and intends to continue talking with Dish (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DISH\" title=\"DISH Network Corporation\">DISH</a>) about a deal. Also, Clearwire is no longer obligated to go through with an accelerated 4G LTE buildout should it take the last 3 financing draws available to it (available from August-October). (<a href=\"https://seekingalpha.com/currents/post/853911\" target=\"_blank\"><em>WSJ</em> report</a>)</p><div class=\"tiny-share-widget\" data-id=\"855071\" data-linked=\"Clearwire (CLWR) -2.5% after confirming it&#39;s tapping $80M in financing provided by Sprint...\" data-tweet=\"$S $S $DISH - Clearwire (CLWR) -2.5% after confirming it&#39;s tapping $80M in financing provided by Sprint (NYSE:S); it consists of debt that could be exchanged into Clearwire stock at $1.50/share in the future. The 4G network owner says it hasn&#39;t decided ... https://seekingalpha.com/news/855071?source=tweet\" data-url=\"https://seekingalpha.com/news/855071\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855051\" data-ts=\"1361974525\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855051\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Market preview: U.S. stock futures inch higher ahead of Ben Bernanke&#39;s second day of testimony...</a></h4><b>Market preview:</b> U.S. stock futures <a href=\"http://www.marketwatch.com/story/stock-futures-flat-ahead-of-bernanke-durables-2013-02-27\" target=\"_blank\">inch higher</a> ahead of Ben Bernanke's second day of testimony to Congress and as Europe recovers from the panic attack induced by Italy's election. The S&amp;P Mini is <font color=\"green\">+0.1%</font>. \"Since last Wednesday, the markets are in the process of a slow transition from an overtly bullish phase to a more questionable phase,\u201d says Sarhan Capital's Adam Sarhan. <a href=\"https://seekingalpha.com/currents/post/852761\" target=\"_blank\">Later</a>: Pending Home Sales, Fed's Fisher<div class=\"tiny-share-widget\" data-id=\"855051\" data-linked=\"Market preview: U.S. stock futures inch higher ahead of Ben Bernanke&#39;s second day of testimony...\" data-tweet=\"Market preview: U.S. stock futures inch higher ahead of Ben Bernanke&#39;s second day of testimony to Congress and as Europe recovers from the panic attack induced by Italy&#39;s election. The S&amp;P Mini is +0.1%. &quot;Since last Wednesday, the markets are in the pro... https://seekingalpha.com/news/855051?source=tweet\" data-url=\"https://seekingalpha.com/news/855051\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"855011\" data-ts=\"1361974213\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VHC\" target=\"_blank\">VHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/855011\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VirnetX (NYSEMKT:VHC) +4.7% after a $368.2M jury verdict in its Texas suit against Apple...</a></h4><p>VirnetX (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/VHC\" title=\"VirnetX Holding Corporation\">VHC</a>) <font color=\"green\">+4.7%</font> after a <a href=\"https://seekingalpha.com/currents/post/646121\" target=\"_blank\">$368.2M jury verdict</a> in its Texas suit against Apple (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AAPL\" title=\"Apple Inc.\">AAPL</a>) is upheld. Apple's motions for a new trial and reduced damages were denied, and the company has been ordered to pay $330K in daily damages and $33.6K in daily interest up to final judgment. However, VirnetX's request for a permanent injunction was also denied; the companies have been given 45 days to \"mediate over a license.\" VirnetX says it now plans to withdraw its <a href=\"https://seekingalpha.com/currents/post/541561\" target=\"_blank\">ITC complaint</a> against Apple.</p><div class=\"tiny-share-widget\" data-id=\"855011\" data-linked=\"VirnetX (NYSEMKT:VHC) +4.7% after a $368.2M jury verdict in its Texas suit against Apple...\" data-tweet=\"$VHC $VHC $AAPL - VirnetX (NYSEMKT:VHC) +4.7% after a $368.2M jury verdict in its Texas suit against Apple (NASDAQ:AAPL) is upheld. Apple&#39;s motions for a new trial and reduced damages were denied, and the company has been ordered to pay $330K in daily d... https://seekingalpha.com/news/855011?source=tweet\" data-url=\"https://seekingalpha.com/news/855011\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"854941\" data-ts=\"1361973196\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AOD\" target=\"_blank\">AOD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/854941\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alpine Total Dynamic Divdend Fund&#39;s (NYSE:AOD) board authorizes a share repurchase plan...</a></h4><p>Alpine Total Dynamic Divdend Fund's (NYSE:<a href=\"https://seekingalpha.com/symbol/AOD\" title=\"Aberdeen Total Dynamic Dividend Fund\">AOD</a>) board authorizes a share repurchase plan \"reflect(ing) the Board's belief ... that the market continues to undervalue the (stock).\" Net asset value is estimated at $4.57 vs. yesterday's close of $3.93. Fund president Sam Lieber <a href=\"https://seekingalpha.com/currents/post/788641\" target=\"_blank\">was a buyer</a> of shares a month ago. Shares <font color=\"green\">+2.3%</font> to $4.02 premarket. (PR)</p><div class=\"tiny-share-widget\" data-id=\"854941\" data-linked=\"Alpine Total Dynamic Divdend Fund&#39;s (NYSE:AOD) board authorizes a share repurchase plan...\" data-tweet=\"$AOD - Alpine Total Dynamic Divdend Fund&#39;s (NYSE:AOD) board authorizes a share repurchase plan &quot;reflect(ing) the Board&#39;s belief . that the market continues to undervalue the (stock).&quot; Net asset value is estimated at $4.57 vs. yesterday&#39;s close of $3.93.... https://seekingalpha.com/news/854941?source=tweet\" data-url=\"https://seekingalpha.com/news/854941\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"854911\" data-ts=\"1361972811\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TJX\" target=\"_blank\">TJX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/854911\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The TJX Companies, Inc. (NYSE:TJX) intends to declare quarterly dividend of $0.145/share, 26%...</a></h4><b>The TJX Companies, Inc. (NYSE:<a href=\"https://seekingalpha.com/symbol/TJX\" title=\"TJX Companies Inc.\">TJX</a>)</b> intends to declare quarterly dividend of $0.145/share, <font color=\"green\">26% increase</font> from prior dividend of $0.115, subject to the approval of board. Forward yield 1.32%. The board authorized to repurchase shares of approx. $1.3B-$1.4B. Shares <font color=\"red\">-1.5%</font> premarket. (PR)<div class=\"tiny-share-widget\" data-id=\"854911\" data-linked=\"The TJX Companies, Inc. (NYSE:TJX) intends to declare quarterly dividend of $0.145/share, 26%...\" data-tweet=\"$TJX - The TJX Companies, Inc. (NYSE:TJX) intends to declare quarterly dividend of $0.145/share, 26% increase from prior dividend of $0.115, subject to the approval of board. Forward yield 1.32%. The board authorized to repurchase shares of approx. $1.3... https://seekingalpha.com/news/854911?source=tweet\" data-url=\"https://seekingalpha.com/news/854911\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"854851\" data-ts=\"1361972024\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCM\" target=\"_blank\">RCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/854851\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Accretive Health (AH) plummets 30% after saying yesterday that its postponing its Q4 and FY...</a></h4>Accretive Health (AH) <font color=\"red\">plummets 30%</font> after saying yesterday that its <a href=\"https://seekingalpha.com/currents/post/853601\" target=\"_blank\">postponing</a> its Q4 and FY earnings results. Raymond James <a href=\"https://twitter.com/thenotablecalls/status/306754520501862401\" target=\"_blank\">suspends its rating</a>, saying: \"No visibility into future results, and are left with more questions than answers.\"<div class=\"tiny-share-widget\" data-id=\"854851\" data-linked=\"Accretive Health (AH) plummets 30% after saying yesterday that its postponing its Q4 and FY...\" data-tweet=\"$RCM - Accretive Health (AH) plummets 30% after saying yesterday that its postponing its Q4 and FY earnings results. Raymond James suspends its rating, saying: &quot;No visibility into future results, and are left with more questions than answers.&quot; https://seekingalpha.com/news/854851?source=tweet\" data-url=\"https://seekingalpha.com/news/854851\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"854841\" data-ts=\"1361971889\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPR\" target=\"_blank\">TPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/854841\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Coach (COH) jump 5.5% higher premarket with rumors flying the retailer may be up for...</a></h4><p>Shares of Coach (COH) jump <font color=\"green\">5.5% higher</font> premarket with <a href=\"https://twitter.com/Street_Insider/status/306755449531793410\" target=\"_blank\">rumors</a> flying the retailer may be up for sale. The jump could be <a href=\"https://twitter.com/mojoris1977/status/306583359830753281\" target=\"_blank\">short-lived</a> though, as the rally appears to be tied to a dealReporter headline which suggests more than what the underlying story does.</p><div class=\"tiny-share-widget\" data-id=\"854841\" data-linked=\"Shares of Coach (COH) jump 5.5% higher premarket with rumors flying the retailer may be up for...\" data-tweet=\"$TPR - Shares of Coach (COH) jump 5.5% higher premarket with rumors flying the retailer may be up for sale. The jump could be short-lived though, as the rally appears to be tied to a dealReporter headline which suggests more than what the underlying sto... https://seekingalpha.com/news/854841?source=tweet\" data-url=\"https://seekingalpha.com/news/854841\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"854801\" data-ts=\"1361971431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZAGG\" target=\"_blank\">ZAGG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/854801\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zagg (NASDAQ:ZAGG) trades 6.5% higher in premarket action after the company&#39;s guidance for FY13...</a></h4><p>Zagg (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ZAGG\" title=\"ZAGG Inc\">ZAGG</a>) trades <font color=\"green\">6.5% higher</font> in premarket action after the company's <a href=\"http://cms.seekingalpha.com/currents/post/853011\" target=\"_blank\">guidance</a> for FY13 surprised to the upside. By appearances, Zagg has made some key moves to lower its debt load to help boost profitability. The stock is on watch for extra volatility today with the name a <a href=\"http://www.nasdaq.com/symbol/zagg/short-interest#.US4IRDA4SSo\" target=\"_blank\">favored target</a> of short sellers.</p><div class=\"tiny-share-widget\" data-id=\"854801\" data-linked=\"Zagg (NASDAQ:ZAGG) trades 6.5% higher in premarket action after the company&#39;s guidance for FY13...\" data-tweet=\"$ZAGG - Zagg (NASDAQ:ZAGG) trades 6.5% higher in premarket action after the company&#39;s guidance for FY13 surprised to the upside. By appearances, Zagg has made some key moves to lower its debt load to help boost profitability. The stock is on watch for e... https://seekingalpha.com/news/854801?source=tweet\" data-url=\"https://seekingalpha.com/news/854801\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"854791\" data-ts=\"1361971430\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZGNX\" target=\"_blank\">ZGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/854791\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The FDA expects to miss its March 1 deadline for approving Zogenix&#39;s (ZGNX +13.2%) application...</a></h4><p>The FDA expects to miss its March 1 deadline for approving Zogenix's (<a href=\"https://seekingalpha.com/symbol/ZGNX\" title=\"Zogenix, Inc.\">ZGNX</a><font color=\"green\"> +13.2%</font>) application for its Zohydro painkiller. The FDA didn't provide a reason for the delay, which may last several weeks, but nor did it indicate that there are any problems with Zogenix's filing. In December, FDA advisors said Zohydro should only get approval once Zogenix has taken measures to help limit opioid abuse. (PR)</p><div class=\"tiny-share-widget\" data-id=\"854791\" data-linked=\"The FDA expects to miss its March 1 deadline for approving Zogenix&#39;s (ZGNX +13.2%) application...\" data-tweet=\"$ZGNX - The FDA expects to miss its March 1 deadline for approving Zogenix&#39;s (ZGNX +13.2%) application for its Zohydro painkiller. The FDA didn&#39;t provide a reason for the delay, which may last several weeks, but nor did it indicate that there are any pr... https://seekingalpha.com/news/854791?source=tweet\" data-url=\"https://seekingalpha.com/news/854791\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"854731\" data-ts=\"1361970573\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DCTH\" target=\"_blank\">DCTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/854731\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">An FDA advisory panel will review on May 2 Delcath&#39;s (OTC:DCTH) application for using its...</a></h4><p>An FDA advisory panel will review on May 2 Delcath's (<a href=\"https://seekingalpha.com/symbol/DCTH\" title=\"Delcath Systems, Inc.\">OTC:DCTH</a>) application for using its Hepatic Delivery System and melphalan hydrochloride to treat patients with unresectable ocular melanoma that is metastatic to the liver. Shares are <font color=\"green\">+2.7%</font> but down from earlier highs. (PR)</p><div class=\"tiny-share-widget\" data-id=\"854731\" data-linked=\"An FDA advisory panel will review on May 2 Delcath&#39;s (OTC:DCTH) application for using its...\" data-tweet=\"$DCTH - An FDA advisory panel will review on May 2 Delcath&#39;s (OTC:DCTH) application for using its Hepatic Delivery System and melphalan hydrochloride to treat patients with unresectable ocular melanoma that is metastatic to the liver. Shares are +2.7% b... https://seekingalpha.com/news/854731?source=tweet\" data-url=\"https://seekingalpha.com/news/854731\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"854601\" data-ts=\"1361969635\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLTR\" target=\"_blank\">DLTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/854601\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Dollar Tree&#39;s (NASDAQ:DLTR) Q4: Comparable store sales increased 2.4% for the period...</a></h4><p>More on Dollar Tree's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DLTR\" title=\"Dollar Tree, Inc.\">DLTR</a>) Q4: Comparable store sales increased 2.4% for the period with a higher average basket size driving the gain. A cut in costs helped the company improve its operating margin rate by 70 bps to 16.2%. The retailer sees comparable sales rising in the low single digits in FY13 and sets it guidance for full-year EPS of $2.54-$2.74 and Q1 EPS of $0.53-$0.58. DLTR <font color=\"green\">+2.2%</font> premarket. (PR)</p><div class=\"tiny-share-widget\" data-id=\"854601\" data-linked=\"More on Dollar Tree&#39;s (NASDAQ:DLTR) Q4: Comparable store sales increased 2.4% for the period...\" data-tweet=\"$DLTR - More on Dollar Tree&#39;s (NASDAQ:DLTR) Q4: Comparable store sales increased 2.4% for the period with a higher average basket size driving the gain. A cut in costs helped the company improve its operating margin rate by 70 bps to 16.2%. The retailer... https://seekingalpha.com/news/854601?source=tweet\" data-url=\"https://seekingalpha.com/news/854601\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"854491\" data-ts=\"1361968490\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSLR\" target=\"_blank\">FSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/854491\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Solar (NASDAQ:FSLR) is now off 14% premarket following last night&#39;s earnings. &quot;It appears...</a></h4><p>First Solar (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FSLR\" title=\"First Solar, Inc.\">FSLR</a>) is now<font color=\"red\"> off 14%</font> premarket following last night's <a href=\"https://seekingalpha.com/currents/post/852971\" target=\"_blank\">earnings</a>. \"It appears that the company is more willing to be aggressive on pricing than we thought ... there's a possibility that H2 financial performance is weaker than the first,\" says BAML,<a href=\"https://twitter.com/thenotablecalls/status/306741441462423553\" target=\"_blank\">downgrading the stock</a> to Sell.</p><div class=\"tiny-share-widget\" data-id=\"854491\" data-linked=\"First Solar (NASDAQ:FSLR) is now off 14% premarket following last night&#39;s earnings. &quot;It appears...\" data-tweet=\"$FSLR - First Solar (NASDAQ:FSLR) is now off 14% premarket following last night&#39;s earnings. &quot;It appears that the company is more willing to be aggressive on pricing than we thought . there&#39;s a possibility that H2 financial performance is weaker than the... https://seekingalpha.com/news/854491?source=tweet\" data-url=\"https://seekingalpha.com/news/854491\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"853981\" data-ts=\"1361958684\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/853981\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.K. Q4 GDP -0.3% Q/Q vs +1% in Q3 and as initially estimated, while on year, GDP revised up to...</a></h4><p>U.K. Q4 GDP -0.3% Q/Q vs +1% in Q3 and as <a href=\"https://seekingalpha.com/currents/search?query=gdp%20U.K.\" target=\"_blank\">initially estimated</a>, while on year, GDP revised up to +0.3% from flat. Sterling was higher vs the dollar but takes a bit of a dive after the data is released and is now <font color=\"red\">-0.1%</font> at $1.5108. The FTSE also loses its gains and is flat. (PR)</p><div class=\"tiny-share-widget\" data-id=\"853981\" data-linked=\"U.K. Q4 GDP -0.3% Q/Q vs +1% in Q3 and as initially estimated, while on year, GDP revised up to...\" data-tweet=\"$FKU $EWU $EWUS - U.K. Q4 GDP -0.3% Q/Q vs +1% in Q3 and as initially estimated, while on year, GDP revised up to +0.3% from flat. Sterling was higher vs the dollar but takes a bit of a dive after the data is released and is now -0.1% at $1.5108. The FT... https://seekingalpha.com/news/853981?source=tweet\" data-url=\"https://seekingalpha.com/news/853981\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"853941\" data-ts=\"1361955593\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/853941\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ben Bernanke&#39;s pledge to continue QE until there are substantial labor market gains helps buoy...</a></h4>Ben Bernanke's pledge to <a href=\"https://seekingalpha.com/currents/search?query=bernanke\" target=\"_blank\">continue QE</a> until there are substantial labor market gains <a href=\"http://www.marketwatch.com/story/asia-stocks-mostly-advance-on-us-cues-2013-02-26\" target=\"_blank\">helps buoy</a> Asian and European shares, although a strengthening yen causes Japan to suffer its biggest two-day drop since November 2011. Japan <font color=\"red\">-1.3%</font>, Hong Kong <font color=\"green\">+0.3%</font>, China <font color=\"green\">+0.9%</font>, India <font color=\"green\">+0.8%</font>. EU Stoxx 50 <font color=\"green\">+0.3%</font>, London <font color=\"green\">+0.5%</font>, Paris <font color=\"green\">+0.4%</font>, Frankfurt <font color=\"green\">+0.3%</font>, Milan <font color=\"green\">+0.2%</font>, Madrid <font color=\"green\">+0.75%</font>.<div class=\"tiny-share-widget\" data-id=\"853941\" data-linked=\"Ben Bernanke&#39;s pledge to continue QE until there are substantial labor market gains helps buoy...\" data-tweet=\"Ben Bernanke&#39;s pledge to continue QE until there are substantial labor market gains helps buoy Asian and European shares, although a strengthening yen causes Japan to suffer its biggest two-day drop since November 2011. Japan -1.3%, Hong Kong +0.3%, Chi... https://seekingalpha.com/news/853941?source=tweet\" data-url=\"https://seekingalpha.com/news/853941\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 AM </div></div></li>","count":73,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}